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In the United States, over 40 million adults suffer from a generalized anxiety disorder 
(GAD), with a 67% increase in overdose-related deaths. Research substantiates the 
efficacy and safety of cannabidiol (CBD) for GAD. Findings show that CBD, sourced 
from industrial hemp, may reduce anxiety symptoms. However, a problem exists for 
individuals deciding to subscribe to CBD’s oral administration because of the inability to 
remain compliant with the regimen. The measured steps that occur when a medication is 
prescribed are lacking when an individual accesses CBD independently. This quantitative 
cross-sectional study was designed to examine whether social cognitive theory explained 
the self-reported likelihood of CBD usage for GAD patients. The five constructs of SCT 
were operationalized: knowledge, expectations, situational perception, self-efficacy, and 
goal setting. The instrument was validated for face, content, and construct validity, and 
internal consistency reliability was established using Cronbach’s alpha. The data 
collected from the sample of 114 were analyzed using stepwise multiple regression. 
There was a significant association with the likelihood of CBD usage found between 
three SCT constructs, namely goal setting, self-efficacy, and situational perception (p< 
0.05). The inclusion of SCT was shown to explain the likelihood of CBD use for GAD. 
The fortification that results from the inclusion of SCT can enhance educational programs 
used to promote using CBD for those individuals struggling with GAD, with the end goal 
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Chapter 1: Introduction to the Study 
This study’s topic was focused on whether the constructs of social cognitive 
theory (SCT) influence participant’s likelihood of using hemp-sourced cannabidiol (see 
Bitencourt & Takahashi, 2018) for generalized anxiety disorder (GAD). Some scientific 
research supports the safety and effectiveness of cannabidiol (Caraballo et al., 2020; 
Cooper et al., 2017; McGuire et al., 2018; Shannon and Opila-Lehman, 2016). However, 
it has become evident that complications exist regarding the various qualities of the raw 
materials and the complexity in dosing the substance (Larsen & Shahinas, 2020). 
McPartland and Guy (2017) concluded that individuals had a broad range of opinions and 
biases regarding the act of taking cannabidiol (CBD). Some were not certain if this was 
akin to using marijuana, while others were not clear if it is legal to transport CBD 
interstate (Mead, 2017).  
Meanwhile, public health experts Trautmann et al. (2016) assert that anxiety and 
depression cost the global economy 1 trillion U.S. dollars annually. Finding a way to treat 
anxiety more effectively provides a four-fold return on each US$ dollars invested 
(Trautmann et al., 2016). While a body of evidence shows how safe and effective CBD is 
in treating GAD, it has become abundantly evident that individuals struggle to find a 
dosing schedule that relieves the ailment (Elms et al., 2019). Therefore, it was warranted 
to examine these attitudes toward CBD through the framework of SCT. Such an 
investigation can provide the opportunity for researchers to gain a deeper understanding 
of the challenges that exist and the potential impediments that might minimize the 




Background of the Problem     
In the United States, over 40 million adults suffer from GAD (Lydiard, 2000). 
Chollet et al. (2013) point to the risk of chemical dependency with chronic usage of 
commonly prescribed antianxiety medications such as Ativan and Xanax. Meanwhile, an 
assemblage of researchers showcased CBD’s safety and effectiveness in treating GAD 
(Garcia-Gutierrez et al., 2020; Tambaro & Bartolato, 2012; Zuardi et al., 2017). 
However, many hesitate to subscribe to CBD’s oral administration therapeutically 
because of quality concerns, costly out-of-pocket expenditures, and preconceived notions 
about the substance (Iannotti et al., 2020).      
Simultaneously, practitioners in the field of holistic health encourage individuals 
to meet health challenges early in the disease progression as a means of minimizing 
suffering, becoming a master of one’s health status, and decreasing the eventual need for 
more invasive, immoderate, and cost-prohibitive treatments (Zamanzadeh et al., 2015). 
Complementary and alternative health (CAM) experts conducted a study that examined  
the dovetailing of preventative therapies with conventional medicine to substantially 
decreasing the out-of-pocket expenditures and increasing the quality of life of the patient 
(Shi & Singh, 2017) while maximizing the populace’s health. Farre and Rapley (2017) 
asserted that because the healthcare system is built upon the biomedical model, many 
individuals are hesitant to veer off in search of those prevention-arced therapies. Other 
researchers found that preventative medicine, when compared to the biomedical model, 




Statement of the Problem 
Anxiety has been determined to be a normal emotional response to danger or a 
potential threat (Belzung & Griebel, 2001). However, that healthy protective emotion can 
become pathological if it becomes uncontrollable, permanent, or maladaptive (Sartori & 
Singewald, 2019). Individuals with chronic anxiety disorders can react to situations or 
objects with dread and panic (Riskind, 1997). Wagner et al. (2005) asserted that the two 
centrifugal treatments for anxiety-related disorders are medications and psychotherapy. 
Stein (2004) revealed that GAD surpasses major depression as a strong predictor of 
various functional impairments and has become a public health issue. Engel (2012) 
opined that biomedicine is influenced by how society has come to conceptualize disease 
collectively. The current medical model is built around traditional health authorities and 
exemplifies a lack of confidence in nonmedical health-supportive models (Engel, 2012).  
Su and Li (2011) ascertained an increased thrust in CAM’s participation in the 
United States, most pronounced between 2002 and 2007. Serendipitously, the 
endocannabinoid system, responsible for creating biological harmony between the human 
body and its environment, was discovered in the 1990s (Di Marzo et al., 2004). Tambaro 
and Bartolato (2012) assert that CBD has shown to be a highly effective and extremely 
desirable substance for treating anxiety disorders. However, these authors noted a gap in 
the academic literature that addresses a lack of operational strategies enabling individuals 
to utilize CBD effectively (Tambaro & Bartolato, 2012). An estimated 40 million adults 
in America are afflicted with GAD, and only one-third of those individuals are in 




this public health dilemma, I contended that there is prudence for this study to 
incorporate the theoretical framework of the SCT as a mechanism to explore theory-
driven attitudes relating to the self-reported likelihood of CBD as an effective treatment 
for GAD.  
Purpose of the Study 
This quantitative study explored an individual’s self-reported likelihood of using 
CBD for GAD. This exploration used SCT as a vehicle to probe into consumer’s attitudes 
toward the use of CBD for GAD. The research’s relevance and uniqueness stem from the 
lack of a theoretical approach coupled with the recent discovery of CBD’s capacity to be 
highly therapeutic for GAD. I applied and measured five SCT constructs, a theoretical 
framework created by a developmental psychologist (Bandura, 2004). For this study, the 
five constructs include knowledge, expectations (including outcome expectations and 
outcome expectancies), situational perception, self-efficacy in using CBD, and goal 
setting. The rationale behind using the SCT is that it may help CBD users effectively 
apply a specific treatment protocol while discovering their effective CBD dosage. I 
sought to ascertain whether these variables will collectively contribute to a more 
comprehensive understanding of an individual’s reluctance or inclination toward 
incorporating CBD as a holistic-oriented solution for GAD. 
Research Questions and Hypotheses 
Research Question 1: To what extent are knowledge, outcome expectations and 




application of an effective treatment protocol associated with the likelihood of CBD 
usage in generalized anxiety disorder?  
H01: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are not associated with the likelihood of CBD usage in 
generalized anxiety disorder.  
Ha1: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are associated with the likelihood of CBD usage in generalized 
anxiety disorder.   
Research Question 2: To what extent are knowledge, outcome expectations and 
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the 
application of an effective treatment protocol associated with the likelihood of CBD 
usage in generalized anxiety disorder, while controlling for age, gender, level of 
education, and generalized anxiety disorder scores? 
H02: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are not associated with the likelihood of CBD usage in 
generalized anxiety disorder while controlling for age, gender, level of education, 
and generalized anxiety disorder scores.   
Ha2: Knowledge, outcome expectations and expectancies, situational perceptions, 




treatment protocol are associated with the likelihood of CBD usage in generalized 
anxiety disorder while controlling for age, gender, education level, and 
generalized anxiety disorder scores. 
Variables in the Study 
The independent variables are the five constructs of the SCT. These five constructs were 
measured as a mechanism to gain valuable data regarding the self-reported likelihood of 
using CBD for GAD. They are: 
• knowledge, 
• expectations (This construct examines both outcome expectations and 
expectancies), 
• situational perception, 
• self-efficacy in using CBD, and 
• goal setting. 
The likelihood of CBD usage is the dependent variable. The five constructs of the SCT 
are the independent variables while controlling for the following covariates, including 
age, gender, education level, and GAD level scores.  
The Perspective of the Theoretical Framework 
This study examines an individual’s ability to use CBD effectively through the 
lens of the SCT. SCT posits that reciprocity transpires within a social context of the 
dynamic interactions between the individual’s personal factors, behavioral and 
environmental factors (Bandura, 1989). Furthermore, personal factors consist of 




prompt a new behavior (Turner et al., 2011). As the health field transforms into a health 
model rather than a model based on disease progression, health promotion needs to be 
built upon a well-constructed goal (Bandura, 2006). The creator of the SCT, Bandura 
(2018), opined that when the goal was to achieve a state of wellness, medical intervention 
alone is not the most conducive in attaining the end goal, which is the state of optimal 
health. Optimal health status is a loftier goal compared to merely minimizing the 
presenting physical or emotional symptomatology.  
Using CBD for GAD differs from the experience of being prescribed a medication 
for the disorder. When one examines how a drug is prescribed and compares this ritual to 
starting a CBD protocol, one can likely begin to understand why a CBD user might 
become less compliant. A written prescription from one’s medical doctor provides some 
built-in structuring that promotes the patient’s compliance with the prescribed medication 
regimen. Firstly, a required initial visit with the physician to discuss presenting 
symptomatology precipitates the prescription. Next, a follow-up visit substantiates the 
need to engage in the prescribed treatment protocol. However, when a consumer 
considers using CBD to treat GAD, there is a less ritualistic formality to support the 
decision to take such an action (Larsen & Shahinas, 2020). Coupling the utility of SCT 
with CBD usage may help fortify compliance by examining the participants’ unique 
ability to negotiate the necessary behavioral change so that the individual is supported to 
use CBD to manage GAD and address a meaningful gap in the current research literature.   
For this research, I probed participants’ self-reported likelihood of using CBD for 




this construct intends to aid in discovering the individual’s current level of understanding 
of the topic of CBD and GAD. The survey questionnaire probed the respondent’s insights 
and facts on these topics of focus in this study. The participant’s breadth and depth of 
understanding of the facts surrounding CBD and GAD are examined in Section 1 of the 
survey instrument. 
Next, I examined expectations, including the outcome expectations and outcome 
expectancies of those considering using CBD for GAD. As an individual is poised to 
make a behavioral change, the person anticipates the outcome that might springboard 
from committing to the new behavior, hence, outcome expectations. Outcome 
expectancies is the value that the individual places upon the ability to perform that new 
behavior (Bandura, 2013). The same source posits that this modification can result from 
roleplaying, thinktanks, and discussing the advantages of the shift in behavior.  
Sharma (2017) asserted the need to determine a level of understanding of the 
individual’s situational perceptions. As the individual realizes that the old behavioral 
style and associated thinking are no longer suiting their needs, the person must shift the 
understanding of tired perceptions and interpretations of the environment and behavioral 
style. Had the old beliefs and perceptions been beneficial, the individual would likely not 
need this self-reflection and reassessment. The SCT construct of situational perception 
often requires rectification of an individual’s distorted perceptions (Bandura, 2018)   
Next in this inquiry is an examination of self-efficacy in using CBD for GAD. 
This study is with the potential of heightening awareness of the behavioral confidence 




is the belief that an individual maintains regarding creating and executing an organized 
action to succeed with the desired outcome. It is noted that self-efficacy continues its 
evolution throughout an individual’s lifetime by acquiring new skillsets (Edinyang, 
2010). The fifth construct examines goal setting to determine how likely the individual 
will experience a successful outcome when taking CBD to minimize GAD. In totality, the 
inclusion of this construct of the SCT will help analyze behavior initiation to fortify the 
ability to maintain a new behavior (Bandura, 2018). Following is a visual of the five SCT 
constructs as they are positioned to lead the individual into incorporating the new health-
supportive habits.  
Figure 1 





















Nature of the Study 
The nature of this study is quantitative research with a cross-sectional design. The 
study design provided the opportunity to acquire a snapshot of the characteristics of the 
attitudes related to CBD usage. Using a Likert scale, my goal was to determine the 
participants’ ease of taking CBD and the potential impediments and challenges of doing 
so, through the SCT lens. My over-arching goal was to facilitate the elucidation of the 
participants’ attitudes regarding the self-reported likelihood of CBD use while examining 
the subject’s measurement of the SCT’s five constructs on the Likert scale designation of 
0-4. These independent variables are knowledge, expectations (including outcome 
expectation and outcome expectancies), situational perception, self-efficacy in using 
CBD, and goal setting toward applying an effective treatment protocol for the population 
seeking to treat GAD with CBD.  
Operational and Constitutive Definitions 
Knowledge: This first construct in SCT. Knowledge references one’s ability to 
gain insight and the propensity to learn the factual elements (Bandura, 1998). This 
section assesses the individual’s understanding of CBD as a potential remedy to relieve 
GAD. This construct is measured by Questions 1-10 in the survey instrument. The 
scoring for this construct, consisting of 10 true or false scale items, has a range of 0 
through 10.  
Expectations: This section assesses the individual’s outcome expectations and 
outcome expectancies regarding the CBD taking for GAD. In this study, the two 




Outcome expectations refer to the likely outcome an individual will experience following 
through with taking CBD for GAD. In contrast, outcome expectancies are representative 
of the valuation placed on that expected outcome (Bandura, 2004). The construct titled 
outcome expectations is measured by Questions 11-15 in the survey instrument, with a 
scoring scale as follows: (0) No, (1) Probably Not, (2) Maybe, (3) Probably, and (4) 
Highly Likely. The construct termed outcome expectancies is measured by Questions 16-
20 in the survey instrument with a scoring scale as follows: (0) Not at all Important, (1) 
Not Very Important, (2) Somewhat Important, (3) Important, (4) Very Important. 
Multiplication of items 11 and 16, items 12 and 17, items 13 and 18, items 14 and 19, and 
items 15 and 20 (Sharma and Petosa, 2014) enabled the summation of expectations of the 
likelihood of using CBD; the score range is from 0 to 80.    
Situational perception: This construct describes how individuals perceive and 
interpret one’s behavior and environment (Sharma, 2017). This section of the survey 
assessed how one’s perception affects the ability to utilize CBD for effectively treating 
GAD. This construct was measured by Questions 21-24 in the survey instrument. The 
scoring scale for situational perception is with the following designations: (0) No, (1) 
Probably Not, (2) Maybe, (3) Probably (4) Highly Likely, and has a range of 0 to 16.  
Self-efficacy: This construct is designated to examine the confidence that an 
individual must exercise (Bandura, 2006) to implement an effective protocol to take CBD 
for GAD. This construct is measured by Questions 25-28 in the survey instrument. The 
scoring scale for self-efficacy in using CBD has the following designations: (0) No, (1) 




Goal setting: The final construct of the SCT investigates the level of confidence 
in one’s ability to pursue a new behavior (Sharma & Petosa, 2014). This construct, 
measured in Questions 29-33, examined the necessary strategy that needs to be 
implemented to set goals for taking CBD effectively for GAD and developing a plan on 
how to reach those objectives. The scoring scale for goal setting is with the following 
designations: (0) No, (1) Probably Not, (2) Maybe, (3) Probably, (4) Highly Likely, with 
the scoring range between 0 to 16.   
Assumptions and Limitations  
While cross-sectional design can serve multiple purposes, one potential barrier for 
this study is recruiting an adequate number of individuals willing to complete the survey 
questions. Also, as I assessed the limitations of self-reporting, there is the recognition that 
it is imperative to be keen to evaluate the level of accuracy and the potential of self-
reporting bias of the data collection (Short et al., 2009). The cross-sectional analysis is 
with the possibility of introducing another limitation in this study. Specifically, while the 
cross-sectional design provides the opportunity to collect relevant data and make a one-
time ‘snapshot’ measurement of the exposure and the outcome, a cross-sectional design 
can impair a researcher’s ability to derive causality in the relationship between exposure 
and outcome (Setia, 2016).  
Another potential limitation is that of generalizability. Although the publicly 
accessible pick-up and drop-off location that was used in recruiting participants for this 
study serves individuals from all SES sectors, a high percentage of participants hail from 




high SES sector compared to other parts of the state and the country. Therefore, because 
this study can likely only be applicable to a narrow sector of the population, the results 
might have poor generalizability. The possibility of flawed generalizability was further 
analyzed in the final two chapters of this study.    
Scope and Delimitations 
Cross-sectional studies are inclined to biases, such as selection bias, information 
bias, nonresponse bias, recall bias, and confounding (Tilahun et al., 2020). The 
propensity to biases can limit a researcher’s ability to prove noteworthy trends that may 
or may not be occurring. An overarching concern is the potential incomplete answers to 
items on the questionnaire, which would negatively influence this study’s internal 
validity. Addressing the issue of generalizability, because this study is being conducted in 
a high SES location, there is a need to conduct further investigations into a cross-section 
of socioeconomic regions to examine the self-reported likelihood of using CBD in 
situations where the ability to make out-of-pocket expenditures assess individuals’ 
varying degrees of abundance.  
Significance of the Study 
The study’s outcome gives rise to vital insights into the self-reported likelihood of 
using CBD as a remedy for GAD. CBD can tone and balance the recently discovered 
endocannabinoid system (Garcia-Gutierrez et al., 2020). Hence, CBD can resolve the root 
cause of symptomatology rather than merely relieving the symptoms of such (Khan et al., 
2020). Practical usage of CBD enables individuals to safely self-regulate and balance 




pharmaceuticals. In comparison, many of the medications commonly used to treat GAD 
have a plethora of side effects such as rebound, injury to the liver and kidneys, and the 
propensity of addiction (Park et al., 2015; Starcevic, 2014).  
Lydiard (2000) reported that GAD has a characteristic of being remitting and 
relapsing for the over 40 million adults in the United States suffering from this most 
prevalent mental illness. Therefore, there is a need to find effective modalities to treat 
GAD other than the commonly prescribed benzodiazepines that, with long-term 
treatment, carry the risk of cognitive and psychomotor function impairment (Lydiard, 
2000). Bridging the field of complementary and alternative health with biomedicine 
would aid in alleviating this public health burden (Mathiesen et al., 1999). Replacing a 
portion of the expected 3.8-billion-dollar market with CBD could positively influence 
societal change.  
Moreover, in the spirit of promoting constructive social change, the overall 
beneficial impacts of applying SCT to CBD use may aid in relinquishing potential 
roadblocks and assist individuals in forming a more comfortable relationship with taking 
CBD for GAD. This study will apply the five theoretical constructs of the SCT to 
heighten awareness of the participants’ theory-driven attitudes while examining the 
respondent’s comfortability when deciding to use CBD for GAD. Furthermore, this study 
aims to determine if the self-reported likelihood of CBD usage is increased through the 





This chapter introduced an overview of this dissertation study, which is the 
probing into the participants’ theory-driven attitudes toward CBD. Moreover, from the 
public health perspective, I sought to highlight the potential positive social change that 
may result from examining the study subjects’ attitudes toward CBD usage for GAD. 
This chapter reviewed the rationale behind the probed hypotheses through the forty-five 
questions instrument presented to the recipients who chose to participate in this research. 
Chapter one also covered the reasoning behind selecting the cross-sectional study design 
using a quantitative methodology for the proposed data collection.  
Consideration of potential assumptions and limitations was explored, including 
the scope and delimitation of this application. For this inquiry, I subscribed to the 
theoretical framework using SCT to explain an individual’s self-reported likelihood of 
using CBD for GAD. The author will move forward to build the case incorporating the 
robust literature review. The overarching goal is that the findings will further clarify how 
individuals can use CBD most effectively to minimize or resolve GAD. Inevitably, the 
act of gaining a greater degree of understanding of the self-reported likelihood of 




Chapter 2: Literature Review 
GAD affects 40 million adults in the United States (Lydiard, 2000). While 
treatable, only 36.9% of those afflicted are in treatment for this most common mental 
illness (Collins et al., 2004). Hoge et al. (2015) affirmed that there are concrete steps that 
one can take to decrease symptoms, but there is little support offered in prevention 
strategies (Christensen et al., 2010). Many health and law experts uphold that the 
influence of biomedicine has sanctioned a conceptualization of a sick-care system that 
lacks preventative care strategies (Cloatre, 2019; Engel, 2012; Sarris et al., 2013). As a 
result, the current medical model-oriented healthcare system upholds the traditionalist 
health authorities’ stayed beliefs, which projects a lack of confidence to engage in a 
nonmedical healthcare model (Engel, 2012). CBD has been proven to effectively treat 
GAD (Garcia-Gutierrez et al., 2020). Still, there is a higher likelihood that patients learn 
about CBD from friends or the internet rather than from a healthcare professional 
(Corroon & Phillips, 2018).  
Focusing on this dilemma might help minimize the divide between alternative and 
complementary healing mechanisms and public health strategies. Su and Li (2011) 
revealed a higher level of participation in these preventative-arced modalities between 
2012 and 2017. And while Tambaro and Bartolato (2012) recognized CBD’s high level 
of effectiveness for treating GAD, these authors also noted that a gap existed in the 
operational strategy to help individuals find their effective dosage. The following 
literature review points to the depth and breadth of the lack of education outside of the 




driven application of SCT while examining the self-reported likelihood of CBD usage for 
GAD.  
For this chapter, I subscribed to Ulrich’s Periodicals directory and PRISMA for 
collecting the peer-reviewed, evidence-based items used to create a full literature review. 
My goal was to provide a more in-depth, evidence-based understanding of the issues 
surrounding the treatment of GAD and the potential impact of applying SCT. Of the total 
of 96 pieces of literature utilized for this research94 of those were from 2000 to 2020; 79 
of those were between 2010 and 2020, while 53 were from 2015 to 2020. Approximately 
50 other journal articles were identified and incorporated into this study because of a 
crucial histrionic perspective the works offered.  
This chapter provides a thorough explanation of the procedure for selecting the 
academic literature. There is a clarification of the reasoning behind the implementation of 
the chosen key search words. I also provide the basis of why I incorporated the five 
constructs of the SCT. I then present the argument as to why the SCT framework was 
appropriate and explained how this theoretical framework has the potential of 
simultaneously contributing to and filling a gap in the scientific literature.   
Conducting the Strategic Literature Review Search 
To create a robust and relevant literature review, I first researched the peer-
reviewed academic journals to see if I would find an abundance of literature that 
showcased the safety and efficacy of CBD. Next, to understand how CBD is most 
effectively dosed, I explored how this substance modulates anxiety in the human body. 




became particularly interested in the complications that might unfold because of the 
freedom of choice and the lack of structure in CBD’s dosing schedule. To meet this 
challenge, I incorporated the five constructs of the SCT as a systematic mechanism to 
explore CBD usage’s likelihood and how this knowledge can enable an individual to find 
the most effective dosage of CBD for treating GAD. The relative newness of the topic 
and the recent discovery of the endocannabinoid system in the 1990s continuously 
revealed numerous gaps in even the most recent literature. To add a histrionic 
perspective, I infused into review some seminal works (Bandura, 1989; Bystritsky et al., 
2012; Sarris et al., 2013; Sharma & Romas, 2012; Short et al., 2009; Smith & Hitt, 2006; 
Wade & Halligan, 2004). 
The following is a description of pertinent academic article topics focusing on the 
safety and efficacy of CBD use. In this literature review, I place equal emphasis on GAD. 
The keywords searched include CBD, cannabidiol, generalized anxiety, GAD, holistic 
health, biomedicine, complementary and alternative medicine, CAM, industrial hemp, 
anxiety-related disorders, generalized anxiety disorders, sleep disorders, and the 
endocannabinoid system. I also focused on the pertinence of the application of the SCT. 
While searching for academic journal articles on SCT, key search words include social 
learning theory, Albert Bandura, theoretical framework, theoretic foundations, self-
regulation, cognitive formulation, Bobo doll experiment.  
The Walden University library was the primary source for the research conducted 
in the databases, including SAGE Journal, ERIC, and Thoreau multi-database search 




frequently searched to create the literature review. A catalog of just under 500 related 
peer-reviewed articles was generated while constructing this study’s format. While 58 of 
the peer-reviewed academic journals were written between 2015-2020 (88%), 94 of the 
sources were written between 2000-2020. Seventy-nine of those sources fell between the 
years 2010 and 2020. The remainder of the journals were included because they 
introduced a vital and relevant historical perspective.  
Because GAD is the focus of this study, I conducted a multi-faceted examination 
of this topic through various databases. From examining areas of specialization in 
pediatrics through geriatric medicine, I sought to gain greater awareness of the 
complexity of the issues that might arise from various stages of the lives of those 
suffering from GAD. Gaining a deeper understanding of the mediation and regulation in 
brain biochemistry from CBD and the commonly prescribed medications was a critical 
step in conducting a relevant literature collection upon which to draw. Looking at CBD’s 
scientific development and attitudes toward CBD from as recent as 2000 to the present 
day is astounding. In total, these various perspectives lent an enriched understanding of 
the complexity of GAD and CBD. My curiosity was piqued as I combed the various 
modalities that remain the frontline treatments, although many questions persist regarding 
the safety of those commonly prescribed treatments.  
Much research was done on the use and effectiveness of CBD for GAD to 
substantiate if there was prudence in conducting this study. Some of the studies revolved 
around a more in-depth look at the relationship between CBD use and medical protocols 




about COVID-19 and CBD usage. Some of the research was regarding the increase in 
GAD because there was a global pandemic unfolding in real-time. Serendipitously, 
scientists were examining CBD as a substance that modulated the stress response without 
creating the risk of lowering respiration, as is noted in some of the commonly prescribed 
antianxiety medications. Some of this research incorporated MRIs into the assessment of 
the brain anatomy to determine changes before and after CBD usage, as noted in the 
upcoming literature review table (Li et al., 2020). 
To broaden my perspective, I also explored the research that was currently being 
conducted in countries other than the United States. The information of the various 
studies in the international locations as well as the United States has been included in the 
upcoming literature review table. In the assessment of the feasibility of using CBD for 
GAD, issues of brain biochemistry imbalances (De Gregorio et al., 2019), legal issues 
(Cloatre, 2019), and potential medication and herb interactions were assessed (Boparai et 
al., 2017). When I felt confident to move forward with examining the ‘likelihood of 
taking CBD for GAD,’ I had thus drawn the conclusion that CBD is safe and efficacious 
for the treatment of GAD. With the uniqueness that each user needs to find their unique, 
effective dosage, it felt prudent to examine the likelihood of taking CBD for GAD. The 
most current significant studies that were of pertinence to this study are listed in the 





Table 1  
Literature Review Table of Topics Pertaining to Generalized Anxiety Disorder 
Author Methods  Peer*review Location Focus Area Source Year 
1 Bauerle  Quant. Yes Germany GAD/COVID Journal 2020 
2 Garcia Quant. Yes Spain Treatments Journal  2020 
3 Iannotti Mixed Yes Italy PPARy/Reg Journal 2020 
4 Li Mixed Yes China MRI/GAD Journal 2020 
5 Twenge Quant. Yes USA COVID/GAD Journal 2020 
6 Bolsani Mixed Yes Brazil CBD/Corti. Journal 2019 
7 Cloatre Qual. Yes UK Med/Law Journal 2019 
8 DeGregorio Quant. Yes Canada Serotonin Journal 2019 
9 Elms Mixed Yes US PTSD/CBD Journal 2019 
10 Linares Mixed Yes Brazil CBD/GAD Journal 2019 
11 Radoi Mixed Yes Romania Clinic/CBD Journal 2019 
12 Sartori Quant. Yes Austria Phar./CBD Journal 2019 
13 Shannon Quant. Yes USA Pediatrics Journal 2019 
14 Baric Mixed Yes Croatia CAM/CBD Journal 2018 
15Bitencourt Quant. Yes Brazil PTSD/CBD Journal 2018 
16 Hallion Qual. Yes USA Util./Worry Journal 2018 
17 Baldwin Quant. Yes UK CNS/Phar. Journal 2017 
18 Boparai Qual. Yes India Herb/Med. Journal 2017 
19 Kendall Quant. Yes USA Recept/CBD Journal 2017 
20 Lee Quant. Yes UK CBD/Regul. Journal 2017 
21 Reiman Quant. Yes USA CBD/Opioid Journal 2017 
22 Jurkus Quant. Yes UK CBD/Fear Journal 2016 
23 Shannon Qual. Yes USA CBD/Sleep Journal 2016 
 
Literature Review Overview 
While all the entries in the literature review table were relevant, some are not self-
explanatory. The first five entries were published the year this dissertation was written. 
With a focus on two of those entries, two of these studies (1, 5) examined CBD use for 
GAD through the unfolding of the COVID-19 pandemic. Some of the works in the 




influence, and effectiveness of CBD on brain biochemistry- in entries 3, 4, 8, 12, 19, and 
20. While the majority of the entries were quantitative, I carefully incorporated a balance 
of meta-analysis studies in entries 3, 4, 6, 9, 10, 11, and 14. To elucidate the perspective 
of the patient/respondent, several qualitative studies were integrated into the literature 
review, including entries 7, 16, 18, and 23. All entries were rechecked to ensure that each 
journal article accessed was peer-reviewed. 
Social Cognitive Theoretical Framework 
The SCT is utilized to support a person’s ability to influence their actions and, 
therefore, increase the likelihood of producing a particular result (Bandura, 1999). The 
same source reveals that the SCT was developed in the 1960s by Albert Bandura. This 
theoretical framework was initially referred to as the social learning theory (Bandura & 
Walters, 1977). Bandura professed that SCT could enable subscribers to contribute 
positive attributes to one’s life circumstances rather than merely being a product of such 
(Smith & Hitt, 2006). Bandura (2011) asserted that SCT was rooted in an agentic 
construct of a human’s ability to develop, adapt, and change. The creator of SCT posits 
that behavioral change occurs within a social context as reciprocity occurs between the 
individual, the individual’s behavior, and the individual’s environment (Bandura, 2006).  
In an analysis of how practical the application of SCT has been in similar studies, 
researchers utilized SCT as the theoretical framework for chronic health condition 
interventions (Tougas et al., 2015). Another study showcased the efficacy of applying the 
SCT in developing electronic health design platforms (Grace-Farfaglia, 2019). Domino et 




determining SCT was highly beneficial in examining corporate accounting professionals’ 
attitudes and behaviors. Lin et al. (2020) explored the mediation of hyper-competition 
and dysfunctional conflict in complex work environments by applying the SCT 
framework. The SCT was used in a study that probed the effect of CBD on the act of 
simulated public speaking and determined a high success rate (Bergamaschi et al., 2011). 
Knapp et al. (2020) also utilized the SCT to understand the complex multi-lateral 
composition of present-day work environments.           
This study will explore the participants’ self-reported likelihood of using CBD for 
GAD while subscribing to the SCT framework. The application of the first construct of 
the SCT is knowledge. Here, I examined the experience the participants currently 
maintain on CBD use for GAD. The second construct is pointed at gaining a deeper 
understanding of the subject’s expectations, including outcome expectations and outcome 
expectancies by and for the participant. The third construct of SCT is referred to as 
situational perception. Here, the intention was to gain insight into the study participant’s 
perception and interpretation of their behavior and environment (Sharma, 2017) that 
might inhibit one from successfully embarking upon a CBD regiment to treat GAD. 
Self-efficacy in using CBD, the fourth construct, allows for an examination of 
CBD usage self-efficacy to be considered and assessed. This concept enables the assessor 
to gain insight into the subject’s degree of behavioral confidence for implementing a 
beneficial CBD protocol (Bandura, 2004). The fifth construct of the SCT is that of goal 
setting. Bandura (2018) professed that the use of goal setting relates to an increase in self-




the SCT is that doing so will facilitate a more in-depth understanding of the attitudes and 
the self-reported likelihood of CBD use by examining the respondent’s confidence level 
in using CBD as an effective holistic health modality for GAD.  
Prevalence of Generalized Anxiety Disorder 
Belzung and Griebel (2001) contended that anxiety is considered a normal and 
healthy response to threats and dangerous circumstances. Yet this healthy emotion has 
become maladaptive, pathological, and even permanent (Sartori & Singewald, 2019) for 
upwards of 20% of individuals between 18-54 living in the United States (Bandelow & 
Michaelis, 2015). These statistics equate to approximately 40 million adults afflicted with  
GAD (Collins et al., 2004). The United States Census Bureau stressed that there was a 
tripling increase in GAD in adults in May of 2020 compared to the previous year 
(Twenge & Joiner, 2020). 
Barlow (2000) demonstrated that certain circumstances or objects could trigger a 
person to have a panic attack or overwhelming and sometimes chronic feeling of dread, 
 while noting that essential determinants in developmental learning and psychology aided 
in understanding anxiety and related disorders. The current medical-arced health care 
system proclaims that there are two primary treatments for GAD: psychotherapy and 
prescription medications (Wagner et al., 2005). Meanwhile, some alternative and 
complementary researchers expressed concern that treating anxiety disorders is highly 
influenced by the intervention-arced healthcare system rather than implementing a 




protocols that could be beneficial with the inclusion of adaptogens such as CBD to treat 
GAD (Zamanzadeh et al., 2015).   
Complementary and Alternative Medicine 
In the United States, the medical-oriented healthcare system has become more 
accepting of complementary and alternative preventative-arced and health-building 
modalities (Perard et al., 2015). Zamanzadeh et al. (2015) stressed that merging a holistic 
health system of care with biomedicine could improve healthcare methodologies. The 
same researchers asserted that this act could prompt the creation of appropriate 
preventative public health education campaigns. Pelletier (1991) built an impressive case 
regarding cost-effectiveness resulting from prevention strategies with a greater focus on 
health promotion rather than mere intervention-styled medication modalities.  
Meanwhile, Cloatre (2019) examined the convergence of traditional healing 
techniques as they abutted with biomedicine. Specifically, I explored how ancient health 
modalities have become the ‘pseudo’ treatments as biomedicine and law have become 
centrifugal to the current healthcare system. This health law expert (Cloatre, 2019) asserts 
that- while regulatory systems are recognizing various branches of ancient healing arts, 
these modalities are being operationalized on assumptions disqualifying the product 
because it does not resemble the medical model treatment strategies. Niemeyer et al. 
(2013) showcased those medical practitioners often consider CBD to be a feasible and 
effective treatment for the patient’s GAD yet remain uncomfortable recommending an 
herbal supplement. Throughout the peer-reviewed literature, there was a familiar 




prescription for medication rather than embarking upon the process of experimenting 
with herbals remedies, such as CBD.     
Epidemiology of Generalized Anxiety Disorder 
The World Health Organization’s perspective on the ramifications of anxiety 
disorders is showcased in a journal article that focuses on the gravity of anxiety 
disorders- revealing the cumbersome economic burden to which this nation is subjected 
because of the gross underdiagnosing and undertreatment of these mental illnesses (Costa 
e Silva, 1998). A group of researchers conducted a cross-sectional study of 15,704 
residents to assess GAD from an epidemiological stance due to COVID-19, concluding a 
spike in the GAD prevalence (Bauerle et al., 2020). Meanwhile, there was an increase in 
the number of researchers resounding the safety and efficacy of CBD for inflammation, 
sleep disorders, and GAD (Caraballo et al., 2020; Cooper et al., 2017; McGuire et al., 
2018; Shannon and Opila-Lehman, 2016). While examining how individuals can use 
CBD most effectively for an epidemic proportion of GAD, I revisited the challenge that 
exists when users are left to determine what dosage is most useful for this prevalent 
health threat. Moving toward a solution to de-escalate this health impediment would be a 
giant step toward alleviating considerable strain on the public health arena while positing 
social change.  
Reiman et al. (2017) defended that not only is CBD poised to treat the root cause 
of GAD, but CBD is a safe and effective treatment that can support patients to move 
away from even those highly-scrutinized opioid medications so frequently prescribed for 




revealing that 97% of those interviewed strongly agreed/agreed that cannabis use enabled 
a decrease in opiate usage, while 81% strongly agreed/agreed that cannabis provides 
more pain relief than opioids. Caraballo et al. (2020) highlighted the safety, effectiveness, 
and tolerability of CBD with children with a mean age of 10.5 years. Garcia-Gutierrez et 
al. (2020) conducted a review to determine the potential for using CBD to treat GAD 
through the lens of epidemiology. These scientists determined that CBD is a safe and 
effective treatment for GAD by assessing the preclinical, clinical, epidemiological, and 
human experimental studies. 
Generalized Anxiety Disorder and the Standard Biomedical Treatment 
Baldwin et al. (2017) confirmed that while pharmaceuticals remain the standard 
medical treatment for GAD, a high percentage of patients abandon the protocol because 
of the untoward side effects, including weight gain and sexual dysfunction. Bourin and 
Thibaut (2013) substantiated that the standard treatment methods include cognitive-
behavioral therapy and psychopharmacological protocols. These researchers elaborate 
those benzodiazepines, albeit highly addictive, remain the frontline treatment for GAD. 
Li et al. (2020) determined that there is recognition of underdiagnosing and undertreating 
GAD, urging general practitioners to be vigilant to the possibility of such developments. 
Wagner et al. (2005) defended that partaking in a regular exercise program aids the brain 
in releasing endogenous cannabinoids that ease anxiousness, urging a holistic approach. 
Taylor et al. (2012) identified evidence supporting the prudence in incorporating 
meditation, yoga, and other prevention-arced stress management techniques when 




manifestations, including GAD. A most recent study (Klotz et al., 2020) highlighted that 
self-initiated CBD usage is high; however, there is a considerable limitation on 
information regarding the potential of interaction with concomitant medications. These 
researchers determined that this lack of data causes many to fall back into taking the 
frequently prescribed benzodiazepines to manage the symptoms of GAD (Klotz et al., 
2020). 
GAD and Alternative & Complementary Medicine Treatment 
In a national study examining the lack of ability to keenly assess and determine 
GAD and the common comorbidity of major depressive disorder, researchers are pointing 
to the need for a blending of biomedicine with complementary and alternative medicine 
practices (Blanco et al., 2014). Sarris et al. (2013) paved the way for further research of 
treating GAD safely and efficaciously with plant-based medications, including CBD. 
This team gleaned that CBD’s regular use was effective in humans’ clinical trials for a 
broad range of anxiety-related disorders. Scientists examining non-compliance issues, 
Bystritsky et al. (2012), demonstrated that those participants achieving a 50% reduction 
in GAD symptoms were more likely to discontinue alternative therapies after eighteen 
months. This common theme is reiterated in other studies, confirming that 
complementary and alternative medicine for GADs continues to showcase limitations 
(Baric et al., 2018; Radoi & Cicu, 2019). These researchers pointed to non-compliance 
with the CAM practice- usually falling off the protocol not long after the individual feels 
the relief of the symptom of GAD and begins to forget the level of discomfort previously 




Treating Generalized Anxiety Disorder with Cannabidiol 
Kendall and Yudowski (2017) highlighted the brain biochemistry disorder that 
springboarded from imbalances in the endocannabinoid system and focused on the 
signaling pathways of the CB1 receptor- specifically the role of modulating homeostasis 
processing and synaptic plasticity. In a peer-reviewed case study, Shannon and Opila-
Lehman (2016) determined that CBD oil can be a safe and effective treatment even in 
pediatrics- for reducing GAD and improving sleep disturbances commonly associated 
with post-traumatic stress disorder. Shannon et al. (2019) conducted a large retrospective 
case series examining CBD’s efficacy on generalized anxiety and sleep disorders. These 
researchers discovered that the inclusion of CBD positively impacted the participants’ 
anxiety scores as quickly as in a 30-day response in this clinical trial, with a notable 
decrease in anxiety level scores in 57 of the total 72 adult samples (79.2%). This study’s 
scientists also determined that the sleep scores (66.7%) showed an immediate 
improvement in 48 participants. 
Seeking to determine how CBD impacted other complex mental health diagnoses, 
McGuire et al. (2018) assessed CBD’s safety and efficacy in various mental health areas, 
including schizophrenia. These researchers determined that CBD was well tolerated, had 
a clear impact on patients, and was a promising prospect as a new adjunctive therapy. 
Lee et al. (2017) demonstrated anti-anxiety effects through the regulation of emotional 
processing and emotional memory in response to the use of CBD. De Gregorio et al. 




activation of the 7-HT1A receptor and aids in repairing faulty 5-HT transmissions in 
neuropathic-based pain status.  
Jurkus et al. (2016) discovered that CBD caused a reduction in learned fear by 
relinquishing memory reconsolidation of the fear (Linares et al., 2019). In turn, CBD 
proved efficacious in enhancing extinction- the process through which “exposure therapy 
inhibits learned fear.” In this case study, Shannon and Opila-Lehman (2016) determined 
that CBD oil can be a safe and effective treatment for reducing GAD and improving sleep 
disturbances commonly associated with post-traumatic stress disorder. Zuardi et al. 
(2017) assembled a compilation of academic journal results, all of which supported 
CBD’s efficacy in treating GAD, including social anxiety, post-traumatic stress, 
obsessive-compulsive, social phobia, and panic disorders. 
Applying Five Constructs of SCT to Explain the Likelihood of Using CBD for 
Generalized Anxiety Disorder 
With the recognition of the obviousness that many individuals are without the 
behavioral fortitude to maintain consistency with a CAM remedy compared to taking a 
prescribed drug, I sought to fortify this research with the social cognitive theoretical 
structure. Recognizing that there is inadequate research regarding the challenge of 
discovering one’s effective dosage of CBD (Miller et al., 2019), this framework can serve 
to unfetter this typically complex process by applying the five constructs of the social 
cognitive theoretical framework. This study is designed to consider the participants’ 
current beliefs and behavioral styles of operating. Serendipitously, SCT can help fortify 




 In the 1960s, this theoretical framework was first named the social learning 
theory by the creator Albert Bandura (Smith & Hitt, 2006). In 1989 this learning theory 
was transformed into the SCT focused on the impact of social influence and emphasized 
internal and external reinforcements (Turner et al., 2011). As extracted from the SCT, 
those variables include knowledge, outcome expectations and expectancies, situational 
perception, self-efficacy in using CBD, and goal setting. Each construct of SCT aids in 
clarifying the participants’ strengths and weaknesses regarding the modification of a 
specific behavior. The SCT has been proven to be a highly effective framework in 
critically examining participants’ behavioral modification mechanisms (Bandura, 2018) 
by bringing clarity to the behavior that needs support through this process of 
transformation. 
Potential Influence of Construct Knowledge on Likelihood of Using CBD for GAD  
Each participant brings into the experience of taking CBD their unique biases, 
assumptions, and level of knowledge of the substance. Behavior change is accomplished 
by compiling facts on the topic in focus through informative sheets, talks, and lectures 
(Sharma & Petosa, 2014). A study conducted to assess the knowledge level of herbal 
medicines of undergraduate medical students determined a lack of awareness that the 
potential of herb/drug interactions exists (Boparai et al., 2017). In the process of enabling 
an individual to become an authority of one’s health status, employing this construct 
positions a researcher to unequivocally understand if further training is necessary and 
precisely where to pinpoint an educational initiative. This process of gaining a clear 




omitting key details (Turner et al., 2011), which might disable the individual from finding 
the effective dosage of CBD for the treatment of GAD. 
The Role of Outcome Expectations/Expectancies When Considering CBD for GAD  
The purpose of this construct of the SCT was to aid the participant in examining 
the expected result of using CBD for GAD. While each contributor enters into the 
process of taking CBD with different preconceived outcomes, examining this construct 
alerts the researcher to the anticipated consequence, or expectation, that might result from 
engaging in the behavioral change process (Bandura, 2018). The outcome expectancy 
construct emphasizes the value that the human subject places on the likely outcome that 
springboards from the act of making the given behavioral change (Sharma, 2017). This 
information will help a researcher gain a deeper understanding of how driven the 
participant will likely be while considering CBD for GAD. In comparison, the 
modification of outcome expectations evolves by discussing the behavioral change 
benefits, while outcome expectancies develop by discussing the value placed upon the 
anticipated behavioral adaptations. 
The Rationale for Situational Perception When Considering CBD for GAD  
There is prudence in gaining knowledge from the survey respondent’s current 
situational perceptions and interpretation of the level of awareness of the health-
supportive attitude within the context of one’s environment (Manjarres-Posada et al., 
2020). The knowledge gained by understanding an individual’s situational perceptions 
can rectify the dysfunctional behavior by recognizing those current and past 




their perceptions and interpretations to aid in increasing the likelihood to attain the end 
goal of gaining the fortitude to follow through with a health-supportive behavioral change 
(Smith & Hitt, 2006). Thus, this newly developed skillset can increase the likelihood of 
acquiring a health-supportive habitual behavior.    
Self-Efficacy in Likelihood of Using CBD for Generalized Anxiety Disorder 
Having confidence in one’s capacity to follow through with new behavior is an 
element that all change-makers need to contend with while making an essential health-
supportive transition. Researchers Shamizadeh et al. (2019) tested behavioral confidence 
in a study focusing on prediabetes patients. These scientists concluded that there was 
indeed value derived from applying the SCT- as it assisted those in making lifestyle 
changes that guided the participants in modifying the individual’s familial propensity to 
prediabetes. The role of the theoretical framework in this study was to gain a higher level 
of insight into the subject’s belief in their ability to pursue the new behavior of taking 
CBD for minimizing or resolving their GAD.  
Gaining a more in-depth understanding of what practical steps (Turner et al., 
2011) need to be taken to turn the intention of taking CBD into a health-supportive 
behavior is the pinnacle goal. Bandura (1989), the creator of this theoretical framework, 
proclaimed that there is value in understanding how an individual can execute a course of 
action to enable a health-supportive change. Providing an individual with specific 
behavioral change techniques can aid in increasing confidence in implementing a 
holistic-arced treatment rather than a mainstream medical treatment protocol (Turner et 




Examining Goal Setting as One Seeks to Treat GAD with Cannabidiol 
Through the SCT application, one must notice the interaction within and between 
the five constructs. Also, Bandura (2011) educated that there is reciprocity between the 
individual, the person’s environment, and the subject’s response to stimuli through 
achieving goals. This over-arching theme of the act of goal setting aids the participant to 
glean a snapshot of precisely where to focus on those necessary shifts in awareness to 
enable the health-supportive behavioral change (Manjarres-Posada et al., 2020). Sharma 
(2017) defended that modification of self-control is constitutionalized by setting a goal, 
monitoring one’s behavior, and the inclusion of an award system for the reinforcement of 
accomplishing the given health-supportive change. Because taking CBD for GAD 
necessitates that every individual discovers one’s effective dosage, goal setting is a 
critical construct of the SCT when seeking to heighten compliance and increase the 
likelihood of using CBD successfully. 
Summary 
Through the lens of public health, it has become obvious that GAD is made even 
more complicated because of the lack of effective treatment strategies other than the 
commonly prescribed pharmaceuticals (Bolsoni et al., 2019; Bourin & Thibaut, 2013). A 
band of researchers has CBD clearly in focus as a safe and efficacious treatment for not 
only the management of GAD the is scientific evidence showcasing that CBD can even 
eliminate GAD (Caraballo et al., 2020; Cooper et al., 2017; McGuire et al., 2018; 




affliction characterized by agitation and worry- and can be debilitating without 
appropriate monitoring and applying suitable treatment strategies.    
In this chapter, I critically examined the most current research, measurements, and 
published data that showcased this study’s focus areas. These focal areas included the 
incidence and prevalence of GAD, the most common and easily accessible biomedicine 
treatments, and the potential benefits and risks of each. This literature review included an 
abundance of primary academic research exploring the feasibility and likelihood of using 
CBD to treat GAD. This chapter showcased how the SCT can help individuals find an 
effective dose of CBD for GAD while addressing a gap in the scientific literature. 
Finally, incorporating the SCT served as the theoretical framework to explore the 
participants’ self-reported likelihood of using CBD for GAD. Moreover, I included a 
robust number of works articulated by key theorists into the section to expose’ how this 
study benefited from SCT’s inclusion. Incorporating the robust literature review provided 
the anchor to pivot to the research methodology- which served to elucidate how this 




Chapter 3: Research Methods 
Introduction 
The purpose of this quantitative study was to explore the study respondent’s self-
reported likelihood of the inclusion of CBD to manage or resolve GAD. The rationale for 
the study design that was chosen for this study is outlined in the first section of this 
chapter. The stages of the study are thoroughly defined throughout this section. 
Beginning with the fortification of the SCT, the goal was to gather information from the 
participants to understand the role that attitudes play in deciding to use CBD to manage 
or alleviate GAD symptoms. Accessing this data was enabled by my quantitative research 
questions:  
Research Question 1: To what extent are knowledge, outcome expectations and 
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the 
application of an effective treatment protocol associated with the likelihood of CBD 
usage in generalized anxiety disorder?  
H01: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are not associated with the likelihood of CBD usage in 
generalized anxiety disorder.  
Ha1: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are associated with the likelihood of CBD usage in generalized 




Research Question 2: To what extent are knowledge, outcome expectations and 
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the 
application of an effective treatment protocol associated with the likelihood of CBD sage 
in generalized anxiety disorder, while controlling for age, gender, level of education, and 
generalized anxiety disorder scores? 
H02: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are not associated with the likelihood of CBD usage in 
generalized anxiety disorder while controlling for age, gender, level of education, 
and generalized anxiety disorder scores.   
Ha2: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are associated with the likelihood of CBD usage in generalized 
anxiety disorder while controlling for age, gender, education level, and 
generalized anxiety disorder scores. 
The uniqueness of this study stemmed from the prior absence of applying the SCT 
in CBD usage. Furthermore, SCT probed into the respondent’s attitudes regarding finding 
the most effective CBD dosage to minimize GAD symptoms. The research’s relevance 
stemmed from the innovative pairing of the under-researched issue of the complexity of 
finding one’s effective dosage of CBD with the SCT’s theoretical framework. I gauged 
the participants’ likelihood of CBD usage by measuring the five constructs of SCT, 




and goal setting. The over-arching goal was to find a more concrete way to teach 
individuals how to adhere to a CBD regiment in a manner that is most specific and 
effective for GAD. Inclusively, the SCT constructs increased awareness of the 
participants’ inclination or reluctance to take CBD as an effective nonmedical remedy to 
treat GAD.  
To enrich the understanding of the basis of this study, I am seeking to inform the 
reader of each of the chosen methodology elements employed to enable in-depth research 
and data collection. As a mechanism of increasing awareness of individuals’ attitudes 
toward CBD usage, I am covering the rationale for examining an individual’s self-
reported likelihood of using CBD while applying the SCT. I provide a thorough 
explanation of how I am operationalizing the variables as a mechanism to gain a more 
robust understanding of the participants’ self-reported likelihood of using CBD to 
minimize acute or chronic anxiety. In this chapter, I cover the objective of the data 
analysis, as well as data management. I am thoroughly addressing the instrumentation 
and operationalization of constructs. I am presenting the steps taken to increase validity, 
reliability, and other potential breaches of trustworthiness.  
The Rationale for Research Methodology and Study Design 
The study was designed to probe the survey respondent’s likelihood of using CBD 
to treat GAD. This cross-sectional study design was suitable for this study to answer the 
research questions while testing the hypotheses. A cross-sectional study design is apropos 
when a researcher seeks to gain data from the sample at a single point in time (Creswell 




deciphering the population’s characteristics such as age, geographical location, and other 
demographical details. In this study, the independent variables were the five constructs of 
the SCT. With the consideration of time constraints, this study had neither prospective 
nor experimental study attributes. I surveyed the respondents over a predetermined 
timeframe, which also fulfilled one benchmark for the rationale of choosing a cross-
sectional research study design. This observational study design allowed for investigating 
the one-time measurement of both the exposure and outcome simultaneously (Setia, 
2016). In an observational study design, it is not a researcher’s role to influence or alter 
participants’ exposure (Barnett et al., 2012), as was the case in this research.     
Independent Variables 
In this study, the five constructs of the SCT were the independent variables. In 
establishing cause and effect through the research methodology, I sought to determine the 
independent variables that would showcase the impact of the respondent’s self-reported 
likelihood of using CBD in this study. Gaskin and Happell (2014) stressed that the 
independent variables are centrifugal to analytical health research. These statistical 
experts defended that the independent variable is the cause; the independent variables 
have stability and are not affected by other variables (Dennis et al., 2000; Gaskin & 
Happell, 2014; Giuliano & Polanowicz, 2008). The independent variables reference the 
study’s condition under examination (Creswell & Creswell, 2013). These researchers 
asserted that a theory is an interlinked group of constructs, otherwise known as 
quantitative research variables. Creswell and Creswell (2013) also proclaimed that these 




encompassed by the variables. The concept of a theoretical rationale is an addendum to 
this definition, which explained the prediction or expectation of the discovered 
relationship (Labovitz & Hagedorn, 1971).    
This study examined the participants’ attitudes surrounding the decision and 
follow-through of taking CBD for GAD while maintaining focus on measuring SCT 
constructs employed in this study. These constructs consisted of knowledge, expectations 
(including outcome expectations, outcome expectancies), situational perception, self-
efficacy in using CBD, and goal setting. These independent variables were analyzed by 
examining the study respondent’s process of managing a CBD treatment protocol to 
minimize GAD. This study aimed to elucidate the data derived from the survey’s 
answers, utilizing a numeric Likert measurement with designations on a scale of 0-4. This 
measurement helped gather data enabling a higher level of understanding of the 
participants’ attitudes regarding the ease, challenges, and potential impediments of 
finding one’s effective dosage of CBD to manage anxiety symptomatology.  
The Dependent Variable in this Study 
The dependent variable in this study was the likelihood of using CBD for GAD. 
The expectation is that the dependent variable would be influenced by the independent 
variable or variables (Aschengrau & Seage, 2014). The same source asserted that the 
‘presumed effect’ of the research study is the dependent variable. In this study, I sought 
to determine the effect of the SCT’s five constructs on the respondent’s self-reported 






The population that comprised the sample for this study was inclusive of 
individuals living in a community in the northeast corner of the state in Connecticut, 
including, but not limited to, Cos Cob, Darien, Easton, Georgetown, Greenwich, New 
Canaan, Norwalk, Redding, Ridgefield, Rowayton, Springdale, Stamford, Weston, 
Westport, and Wilton. The New York communities were Armonk, Bedford Hills, 
Lewisboro, Mount Kisco, Pound Ridge, and South Salem. Individuals from the said 
communities frequent the publicly accessible holistic health center, which served as the 
survey distribution and drop-off location. Individuals frequent this nutrition center from 
throughout the state, as well as the abutting states of New York; Rhode Island to the east, 
and Massachusetts to the north.  
Some of the towns that comprised this study population were within Fairfield 
County, Connecticut, with a population total of 943,332 (United States Census Bureau, 
2019) and a median income of $92,969 between 2014 through 2018. Of those living in 
Fairfield County, 89.9% had a high school diploma or higher, and 47.4% held a 
bachelor’s degree. The same source revealed that those in the study population residing in 
New York hailed from Westchester County constituted a total population of 949,218, 
with a median income of $92,758 (United States Census Bureau, 2019). Those living in 
Westchester County with a high school diploma or higher comprised 87.8%, while those 





Recruitment Procedure, Ease of Participation, and Data Collection 
I collected the data from surveys distributed to approximately 120 individuals 
suffering from GAD through a publicly accessible holistic health center/natural food 
store. While some of this sample was self-referred, others were introduced through 
various practitioners, including psychiatrists, psychologists, psychotherapists, sleep-
disorder clinics, immunologists, general practitioners, rheumatologists, oncologists, and 
advanced practical registered nurses. Additionally, a wide array of holistic-arced 
practitioners also referred individuals to this highly frequented public access 
complementary and alternative health center, including chiropractors, nutritionists, 
acupuncturists, reiki therapists, yoga instructors, public health experts, fitness trainers, 
and physical therapists. These practitioners’ common goal was to help the patients treat a 
wide range of maladies, including anxiety-related disorders. Moreover, this 
complementary and alternative health center offers a wide array of health-supportive 
organic foods, nutraceuticals, homeopathic remedies, and herbal supplements, including 
CBD products. 
I aimed to create a collaborative study involving scientific research with 
community members (Akamani & Hall, 2015). In this study, I sought to gain a more in-
depth understanding of those community participants- gaining valuable data regarding the 
potential complexities of using CBD as a mechanism to treat GAD. To this end, email 
blasts announced the community members’ opportunity to participate in this research. In 
addition, community announcement board postings in the northeast corner of CT, and 




awareness of the opportunity to participate in this study. Social media influencers 
broadened the reach of potential participants struggling with generalized anxiety to 
various mental health platforms, mother’s groups, men’s clubs, and Parent/Teacher 
Associations consisting of individuals residing in New Canaan and surrounding towns 
throughout Connecticut and New York.  
The study survey packets were publicly accessible to potential participants in 
plain, unmarked envelopes. The designated pickup and drop-off hub, located in the center 
of a village, is easily and equally accessible by pedestrians and those driving. For ease of 
accessibility, a curbside pickup was available as a mechanism to mitigate any obstacles or 
barriers to participating in this study. The completed surveys were returned directly to me 
and then placed into a sealed collection box- to guarantee anonymity and relinquish 
potential privacy concerns.  
I discussed the debriefing and exit strategy at the point of drop-off of the survey 
questionnaire to each participant in this study. One critical step in the process of 
participating in this study- the act of taking the survey in and of itself expressed informed 
consent on behalf of the participant (See Informed Consent Form in Appendix A). After 
the participant returned the completed packet, I placed the complete survey questionnaire 
directly into the lockbox owned solely by myself, Margaret Wenzel. Further de-
identification: the participants’ questionnaire packets were assigned a numeric 





To ensure adherence to the standards set forth by Walden University, I exercised a 
significant level of consideration and reflection to what seemed to be even the most 
insignificant of details. For collecting new data, the Walden University Research Ethics 
Approval Checklist was used as a primary guideline. The forty questions regarding the 
ethical standards employed for this study were thoroughly examined and answered. This 
proposal and research design were built so that each answer to those forty questions on 
the Research Ethics Approval Checklist was YES while being as self-critical and 
objective as could be. Simultaneously, these standards prepared me for the Institutional 
Review Board’s pending review following this proposal’s approval (Walden University, 
n.d.). One of the panel experts who aided in the instrument’s creation and final approval 
has a health law background. Having an individual on the panel with expertise in this area 
offered a keen eye for ethical details throughout the medical disclaimer, informed 
consent, and the instrument’s vocabulary.    
Instrument 
Since I was planning to collect data in my workplace, one of the panel experts 
recommended having a preemptive consultation with the Institutional Review Board 
(Walden University, Center for Research Quality, n.d.). As a result of this meeting and 
then reviewing the available guidelines regarding data collection at one’s workplace, it 
was recommended that the recruitment, data collection, informed consent would be 
achieved in a manner that hinders a researcher from knowing which individuals 




preferred recruitment methods through collecting data and gaining informed consent were 
thoroughly considered and addressed. Next, these methods were combed and validated by 
a panel of seven experts. All reviewers can access a copy of the Informed Consent de-
identification process in Appendix A for complete details of this process. 
Operationalization of the Five Constructs 
This first construct in SCT, knowledge- referenced one’s ability to gain insight 
and their propensity to learn the factual elements (Bandura, 1998). This section probed 
the study participant’s prior understanding of CBD. The knowledge section also assessed 
the individual’s understanding of CBD as a potential remedy to relieve GAD. The scoring 
for the construct knowledge consisted of 10 true or false scale items and had a scoring 
range of 0 through 9.  
The second construct assessed the individual’s expectations and expectancies 
regarding the taking of CBD for GAD. In this study, the two classifications of this 
construct: Outcome expectations referred to the likely outcome an individual will 
experience while following through with taking CBD for GAD. In contrast, outcome 
expectancies were representative of the valuation placed on that expected outcome 
(Bandura, 2004). The scoring scale for outcome expectations consisted of items 10-14 
and was with a scoring range as follows: No (0), probably not (1), maybe (2), probably 
(3), highly likely (4).  
The scoring scale for outcome expectancies consisted of items 15-19 and was with 
a scoring as follows: Not at all important (0), not very important (1), somewhat important 




and 16, items 12 and 17, items 13 and 18, and articles 14 and 19 (Sharma & Petosa, 
2014) enabled the summation of expectations regarding the likelihood of CBD usage; the 
scoring range was from 0 to 80. The third construct described how individuals perceived 
and interpreted one’s behavior and the environment (Sharma, 2017). This section 
assessed how one’s situational perception affected the ability to effectively utilize CBD 
for treating GAD. The scoring scale for situational perception consisted of items 20-23 
and was with the following designations: No (0), probably not (1), maybe (2), probably 
(2), highly likely (4), and had a range of 0 to 16.  
The fourth construct was designated to examine the confidence an individual must 
exercise (Bandura, 2006) to implement an effective protocol for taking CBD for GAD. 
The scoring scale for self-efficacy in using CBD consisted of items 24-27 and was with 
the following designations: No (0), probably not (1), maybe (2), probably (3), highly 
likely (4), and was with a scoring range of 0 to 16. The fifth construct of the SCT 
investigated the level of confidence in one’s ability to pursue a new behavior (Bandura, 
2018). This construct examined the necessary steps that needed to be taken to set goals 
for taking CBD effectively for GAD and developing a plan on how to reach those 
objectives. The scoring scale for the construct of goal setting consisted of items 28-31 
and was with the following designations: No (0), probably not (1), maybe (2), probably 
(3), highly likely (4), and was with a scoring range of 0 to 16. The scoring for the 
dependent variable- Likelihood of CBD Usage (Item 32) had the following designations: 
Not at all (0), probably not (1), maybe (2), probably (3), and highly likely (4), and was 




Sample Size Calculation 
As this study was poised to investigate the self-reported likelihood of taking CBD 
for GAD, there were five predictor variables: knowledge, outcome expectations and 
expectancies, situational perception, self-efficacy in using CBD, and goal setting. The 
effect size = 0.15 (medium), the alpha level = 0.05, the power = 0.80, and number of 
predictors 9 (five constructs of SCT and 4 covariates). Using these indices in G*Power, it 
was determined that a sample size of 114 participants would confer a medium effect size. 
I determined the sample size by creating a scenario whereby numerous observations were 
provided to replicate data opportunities in the statistical sample (Stamatopoulos, 2019), 
utilizing G*Power 3.1.9.7 statistical power analysis. However, because there was a 
relatively low number of respondents (114), this left some concern that an analysis of 
subgroupings would perhaps not have the power to be applied to a more extensive 
population. Further coverage of this potential issue will be conducted in chapter five. 
Data Analysis Plan 
For this data analysis, I sought to determine the independent variables’ ability to 
predict the dependent variable- the likelihood of using CBD for GAD while controlling 
for age, gender, education level, and GAD scores. The primary objective of this cross-
sectional study was to investigate the associations between the variables while seeking to 
determine the moderating effects of age, gender, level of education of the participants, 
and GAD scores. To gather this data for analysis, I had chosen the following sequence of 




Alpha was run in SPSS 25 for the purpose of assuring internal consistency reliability of 
the purpose-built survey questionnaire instrument. 
Included in the data analysis plan, the descriptive statistics of the independent 
variables, including knowledge, outcome expectations and expectancies, situational 
perception, self-efficacy, goal setting, and the dependent variable likelihood of CBD 
usage, enables the organization and summarization of the characteristics in the data set. 
As a clarifying visual aid, a boxplot of the five constructs allowed for viewers to quickly 
deduce if there was skewness, dispersion, and potential outliers in the data. There was 
prudence in including a Pearson correlation coefficient test as a mechanism to measure 
the strength of the association between the variables. 
I used a stepwise regression analysis in SPSS Version 25 (IBM, 2019). The 
stepwise multiple regression statistical test is in the F tests family, a fixed model, 
specifically with the designation of R2 deviation from zero. The utility of the Adjusted R-
Squared statistical test enabled the adjustment of the statistics dependent upon the 
number of the independent variables in this study (Sharma & Petosa, 2014). As this study 
investigated the likelihood of taking CBD for GAD, there were five predictor variables: 
Knowledge, outcome expectations and expectancies, situational perception, self-efficacy 
in using CBD, and goal setting.  
Management of Data 
For this study, I collected and utilized primary data. I created the instrument 
precisely and purposefully for this research data collection. Much attention was paid to 




2004). Briggs (2015) urged that it is vitally important to take steps to avoid common 
survey issues such as leading questions or another potential bias-arced verbiage. I 
analyzed the independent predictor variables- the five constructs of SCT, including 
knowledge, expectations, situational perception, self-efficacy in using CBD, goal setting, 
and the dependent variable, likelihood of CBD usage. The demographics data was 
examined in the Pearson product-moment correlation statistical test, with the remaining 
baseline variables utilized to identify the potential influence of confounding components. 
In Section 1 of the survey instrument: Knowledge of CBD and GAD, the choices 
for the respondents were ‘true,’ ‘false,’ and ‘don’t know.’ As coded in SPSS, if the 
respondent chose the answer of ‘true,’ the individual received a “1.” If the said 
respondent determined the solution of ‘false,’ or ‘don’t know,’ they received a “0” as 
coded in SPSS. This measurement system prompted the respondent to make a definitive 
response, a technique that researchers discovered helps avoid ambiguity (Liedtka et al., 
2008). In Sections 2, 3, 4, and 5, a Likert scale was utilized whereby these ordinal 
variables had inherent ordering. In the final section of the instrument, Demographics: 
While Question 34- What is your age was a continuous variable, Questions 35-39 were 
the nominal and ordinal variety of variables. 
Validity and Reliability 
Habig (2020) stressed that the utmost advantage of a cross-sectional study was to 
examine the absence or presence of outcome or exposure at a given time point. While all 
research is subject to internal and external threats to validity, great care was taken, and 




was well represented by randomizing the wide variety (cross-section) of individuals who 
accessed this research survey. From the conception of this topic, I applied critical 
thinking to develop the research question. Its complexity provided limitations of the 
probability of an alternative explanation that might account for the findings (Ditterich, 
2010). This same academic source opines that it is vital that researchers strategically 
utilize statistical controls to reduce threats to internal validity.  
A seven-person panel of experts agreed upon the instrument’s face and content 
validity with an end goal of minimizing threats to internal validity. This consultant board 
of experts was a thoughtfully comprised group of adept professionals. All panelists have 
areas of expertise in mental health, public health, linguistics, and pharmacology (See 
Appendix B). I tested the reliability by examining the standard deviation and the mean 
similarities between groups, a method that has been deliberated by other scientists (Nijjar 
& Khan, 2017).  
Internal validity for each of the subscales was conducted to ensure the reliability 
of the instrument. Measuring the internal consistency was achieved through the 
application of Cronbach’s alpha. This process provided clarity regarding whether the 
questions would produce a reliable measurement of the variables (Tavakol & Dennick, 
2011). This testing procedure was accomplished through the SPSS statistical process 
platform. Cronbach’s alpha provided a summary measuring internal consistency 
reliability by calculating the degree of intercorrelation among all the items that have been 
designed for measuring a construct in the study instrument (Santesson et al., 2020; 




doubling the critical value of 0.24 for a sample size of 114) for each item were the criteria 
used to confirm the factor structure (Sharma & Petosa, 2014; Stevens, 1996).  
Summary 
I conducted this research using the cross-sectional design methodology. This 
study targeted the population of those individuals living in or around the northeast corner 
of Connecticut. Specifically, I focused on those individuals in pursuit of exploring the use 
of CBD for GAD. For randomness, this research opportunity was accessible to all 
individuals, and there was no systematic sampling process. G*Power (Faul et al., 2007) 
aided in determining that 114 respondents were needed to participate in this study. 
Attention to any potential ethical issues was centrifugal to this chapter.  
I created the questionnaire instrument explicitly for this study. The face and 
content validity process had been achieved through an examination by a panel of seven 
health and academic content experts. This chapter included information regarding the 
utilization of Cronbach’s Alpha to test the survey instrument’s psychometric soundness. 
This chapter also covered the statistical tests, including the Adjusted R-squared that I ran 
in SPSS Version 25, to analyze the survey data collection. Cronbach’s alpha was 






Chapter 4: Results 
For this study, I sought to investigate the ability of the five SCT constructs to 
predict the self-reported likelihood of effectively using CBD for GAD. Specifically, the 
purposefully devised survey questionnaire was with the aim to evaluate the constructs of 
SCT: knowledge, outcome expectations and expectancies, situational perception, self-
efficacy, and goal setting. While this study intended to survey individuals with GAD, 
some participants were self-referred. Others were referred to New Canaan Healthfare 
LLC through a wide array of holistic-arced practitioners, including chiropractors, 
nutritionists, acupuncturists, reiki therapists, yoga instructors, public health experts, 
fitness trainers, and physical therapists. These practitioners’ common goal was to help 
patients treat a wide range of maladies, including anxiety-related disorders. 
The location where this study was conducted is a complementary and alternative 
health center that offers a wide array of health-supportive organic foods, nutraceuticals, 
homeopathic remedies, and herbal supplements, including CBD. In a community with a 
high percentage of individuals holding at least a bachelor’s degree, many shoppers have a 
keen interest in the importance of preventative healthcare. Because of this community’s 
high socioeconomic status, most shoppers have the disposable income to comfortably pay 
out-of-pocket for products that might be considered luxury items to those in a lower SES 
community.  
This chapter covers the data collection process, the analysis of the data through 
IBM SPSS Version 25, and the study results. This results section includes charts and 




results of this data analysis are organized into three sections. The first section describes 
how the variables were operationalized using the SCT constructs. Following, also in the 
first section, is an explanation of the data collection methods. The information in the 
second section describes the operationalization of the constructs in answering the 
research questions. As described in the third section, I implemented a stepwise regression 
analysis to evaluate the research questions. 
Data Collection  
The data collection began after receiving Walden University’s IRB approval 
number for the proposal: 04-27-21-0742839, which expires on April 26, 2022. Strict 
adherence to the guidelines and recommendations of the IRB at Walden University was 
followed through recruitment and collecting the data. The respondents simultaneously 
filled out a GAD-7 self-administered seven-item instrument to measure the severity of 
anxiety symptoms as part of the questionnaire. The GAD-7 is a self-reporting survey 
questionnaire that takes under 10 minutes to complete. In 2006, the GAD-7 self-reporting 
assessment tool was developed by three colleagues: Dr. Kurt Kroenke, Dr. Robert 
Spitzer, and Dr. Janet Williams, which was backed by a grant through Pfizer. For this 
study, this assessment was administered in paper and pencil form. The GAD-7 is also 
available in online formatting. Permission is not required to incorporate the GAD-7 
assessment into an academic study. In a peer-reviewed journal article, A brief measure 
for assessing generalized anxiety disorder: the GAD-7, the conclusion illuminated that 
good agreement existed between the interviewer-administered and the self-reported 




This data collection occurred between May 1, 2021, and June 15, 2021. To each 
participant, I explained that this study aimed to examine the likelihood of CBD use for 
GAD through the lens of SCT. The survey questionnaire included a section whereby I 
assured the participants that their anonymity would be maintained. I also clarified to each 
participant that their consent was implied by filling out the survey, leaving no reason to 
include any personally identifying information on the questionnaire. One hundred thirty 
participants showed interest in completing the survey, were eligible, and collected the 
questionnaire in person. Some participants filled out the survey in privacy in a quiet 
section of the approved facility from where the study took place. In contrast, others 
brought the questionnaire home to complete the survey. Of those hard copy surveys 
distributed, 114 surveys were executed and returned within a time frame of 6 weeks to a 
holistic health facility easily accessible in the heart of a high SES pedestrian-friendly 
community in Fairfield County, Connecticut. I then placed each anonymous survey into 
the pile of other completed surveys in a designated lockbox maintained solely by me. 
This data collection process was explained to and witnessed by each participant. 
A small token of appreciation was then given directly to the study participant after the 
survey was returned- to highlight and substantiate the importance of effectuating the act 
of contributing to social change. In the spirit of minimizing any potential coercion or 
response bias, there was no mention of any form of reward offered before the point in 
time when the respondent’s questionnaire was completed and returned. There were no 




A total of 114 participants completed the survey questionnaire. All the surveys were 
complete, and there were no deletions. 
Research Question 1: To what extent are knowledge, outcome expectations and 
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the 
application of an effective treatment protocol associated with the likelihood of CBD 
usage in generalized anxiety disorder?  
H01: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are not associated with the likelihood of CBD usage in 
generalized anxiety disorder.  
Ha1: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are associated with the likelihood of CBD usage in generalized 
anxiety disorder.   
Research Question 2: To what extent are knowledge, outcome expectations and 
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the 
application of an effective treatment protocol associated with the likelihood of CBD 
usage in generalized anxiety disorder, while controlling for age, gender, level of 
education, and generalized anxiety disorder scores? 
H02: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 




generalized anxiety disorder while controlling for age, gender, level of education, 
and generalized anxiety disorder scores.   
Ha2: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are associated with the likelihood of CBD usage in generalized 
anxiety disorder while controlling for age, gender, education level, and 
generalized anxiety disorder scores. 
Evaluation of Reliability of the SCT Constructs Using Cronbach’s Alpha 
Upon creating the instrument, a panel of seven experts assisted in assessing the 
face and content validity of the survey questions. The goal of this procedure was to 
minimize threats to internal validity. The individuals who comprised this panel were 
high-level experts steeped in various healthcare sectors, including pharmacology, mental 
health, health linguistics, public health, and health law (See Appendix B). Confirmatory 
factor analysis using maximum likelihood method was run in SPSS for each subscale to 
further assess construct validity of the instrument. The Eigenvalue over 1.0, and factor 
loadings over 0.48 (succeeding doubling the critical value of 0.24 for the sample size of 
114) for each line item were the criteria utilized to confirm the factor structure (Sharma 
& Petosa, 2014; Stevens, 1996). All subscales were found to be construct valid.  
To assure internal consistency reliability of the purpose-built study instrument, I 
conducted a coefficient alpha in SPSS (Tavakol & Dennick, 2011). The Cronbach’s alpha 
assessment was used to evaluate each SCT construct operationalized in this study. This 




intercorrelation of the items of the survey design (Santesson et al., 2020; Sharma & 
Petosa, 2014). The result of CA is a number between 0 and 1 (Bonett & Wright, 2014). 
Except for the construct situational perception, the Cronbach’s alphas were over 0.70 and 
thus acceptable. See Table 2 below. 
 
Table 2 
CA for SCT Constructs 
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 Goal Setting 
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        .848 
        .64 
        .829 
        .831 
 
The descriptive statistics of the independent variables- the five constructs of SCT- 
knowledge, outcome expectations/expectancies, situational perception, self-efficacy, and 
goal setting, and the dependent variable- the likelihood of CBD usage for GAD are 








Table 3  
Descriptive Statistics of the Study Variables for RQ1 
                                   N        Mean Std Deviation   Range 
Likelihood of CBD Use     114       2.59      1.342   0-04 
Knowledge                         114       6.59      1.634   1-10 
Expectations                       114       45.95      20.250   0-80 
Situational Perception        114       11.74      2.439   0-16 
Self-efficacy                       114       10.04      3.771   0-16 
Goal Setting                       114        9.22      4.378   0-16 
Note. Dependent Variable: Likelihood of CBD Use. Predictors: Knowledge, 
Expectations, Situational Perception, Self-efficacy, Goalsetting. 
 
The Scoring Range, Mean, and Standard Deviation of the 5 SCT Constructs 
          The scores of the construct knowledge were determined on a scale of 1-10. 
Expectations and expectancies, when multiplied, raise the scoring range to 0-80. 
Perception, self-efficacy, and goal setting have a scoring range of 0-16. While the 
smallest percentage of participants chose not at all likely to use CBD to decrease 
generalized anxiety, the largest percentage of the participant pool revealed highly likely to 
use CBD as an aid in minimizing generalized anxiety. The standard deviation result (SD 
= 1.342) of the DV denotes a clustering around the mean, proving low variability. With a 
scoring range of 0-4, where 0 = no, 1 = probably not, 2 = maybe, 3 = probably, and 4 = 
highly likely. An assessment of the analysis assumption boxplot reveals slight skew and 

















Pearson Correlation Statistical Test 
I ran a Pearson correlation to evaluate the inclusion of the covariates, including 
the five constructs of the SCT- knowledge, outcome expectations, situational perception, 
self-efficacy, and goal setting, with the dependent variable- the likelihood of CBD use. 
From this dataset, one notes the strongest correlation between goal setting and the 
likelihood of CBD use (r = .768, p = 0.00). The next highest correlation exists between 
goal setting and expectations (r = .658, p = 0.00). A high correlation also exists between 
perception and expectations (r = .594, p = .000). Also highly correlated, the likelihood of 
CBD use and expectations (r = .558, p = 0.00), as shown below.      
Table 4 
Correlation Matrix Table of SCT Constructs with DV Likelihood of Using CBD for GAD 
Correlation is significant at the .05 level (1 tailed)* 
Correlation is significant at the .01 level (1 tailed)** 
 
Assumptions for this Study 
One of the assumptions is that the DV- Likelihood of CBD Usage is a continuous 
or interval/ratio variable. The same holds true for the five constructs of the SCT 
Pearson 
Correlation 
 Likelihood of  
 CBD Usage   
                            
 
Knowledge  Expectations Perception Self-
Efficacy 
 Knowledge .241**  
 
    
 Expectations .558** 
 
    .256*     
 Perception .504** 
 









    .104 
 
    .290** 
     .352** 
 
     .658**  
    .207 
 
    .531**               
 
 




constructs. These five constructs- the independent variables, are all measured on a Likert 
scale with the assumption that this provides the ability that one can derive from the 
instrument a summative score. This assumption on the dependent variable (ratio/interval) 
allows for using the multiple linear regression statistical test and is the basis for this 
choice of statistical test for this study. 
The following summary showcases the amount of variance resulting in the three 
predictors- goal setting, self-efficacy, and perception. Statistical significance is seen in 
Model 3. Among the participants surveyed (n = 114), R2 = .643, F (3, 110) = 65.903, p ≤ 
.0001; adjusted R2 = .633. Specifically, Model 3 reveals the statistical significance with 
an adjusted R-square result of .663, explaining the variation total in the dependent 
variable- the likelihood of CBD use. The adjusted R-squared result of .633 highlights that 
combined, these three variables explain 63% of the variance in the dependent variable. 
The R-squared represents the proportion of the variance in the dependent variable, while 
the adjusted R-squared creates an estimation in the total population under examination 





Table 5  
Step-wise Regression Table 
Model R R2 Adjusted R2 SE of the 
Estimate 
      
1 .768 .591 .587 .863 
2 .792 .628  .621  .826  
3 .802 .643 .633  .813  
     
1. Predictors: (Constant), Goal Setting 
2. Predictors: (Constant), Goal Setting, Self-Efficacy 
3. Predictors: (Constant), Goal Setting, Self-Efficacy, Perception 
Dependent variable: Likelihood of CBD Use 
 
Next, the regression provided the results of the analysis of the difference in 
means. Analyzing the sum of squares, I sought to determine if a statistically significant 
difference existed between the means of the three predictor constructs in Model 3. It is 
essential to understand that alone, this test does not specify which of the means are 
different from each of the other means. However, with the established significance level 
of 0.05 (p = .000), we can conclude that there is a statistically significant difference 
between goal setting, self-efficacy, and perception. This analysis of the means provides 
the ability to examine if there are statistical differences among the means of two groups 
or more. This regression output enables the assessor to conclude that the likelihood of 
CBD use is significantly different for at least one of the SCT constructs utilized in the 
analysis of the difference of the means test. The dependent variable- the likelihood of 
CBD usage is significantly different for at least one of the SCT constructs utilized in the 




The residual, also known as the errors of the sum of squares, resulted in a total of 
72.792. This figure is achieved by determining the difference between the likelihood of 
CBD use by subtracting the actual scores from the estimated scores, or vice versa, and 
then squaring that sum. These analyses allow the scientist to examine if there are 
statistical differences among the means of two groups or more. The regression output 
enables the assessor to conclude that likelihood of CBD use is significantly different for 
at least one of the SCT constructs utilized to analyze the difference in the means test. The 
regression sum of squares and the residual sum of squares equate to the sum of squares.          
The subsequent relevant data are an assessment of the analysis of the difference in 
means. Here, I determined the difference between the mean of the dependent variable 
likelihood of CBD use and the actual value, with a result of 203.623. In the analysis of 
the regression sum of squares, the result is 130.831. The analysis of the residual- the 
result is 72.792. The residual sum of squares and the regression sum of squares is equal to 
the total sum of squares.  See Table 6 below.  
Table 6  
Model 3 ANOVA Summary 
Model3  Sum of 
                   Squares 
𝑑𝑓   Mean 
Square 
      F       p 
       
Regression 
Residual  
                       130.831                      




  .662 
65.903 <.0001 
Total                        203.623 113  1.802   
Dependent Variable: Likelihood of CBD Use 





In another statistical test, the coefficients table includes multiple values that 
enable analysts to glean a more thorough understanding of the stepwise regression. The 
stepwise regression was utilized because all the five predictors did not contribute 
uniquely to predicting the dependent variable- the likelihood of CBD use. For this 
stepwise regression, there was a removal of the predictors below a threshold of 0.05. 
Hence, there are no ‘non-significant’ predictors remaining in the model. In Model 3, we 
see the output using the predictors that have contributed most to the outcome variable.  
Under the unstandardized coefficients column, the βeta column holds the 
regression equation, which follows: The Y-intercept is symbolized by ŷ = the likelihood 
of CBD use where the constant value of βo (.256) is added to the value of β1 (.233) and is 
then multiplied by the participants’ actual GoalSetting_Sum score. This equation reveals 
that those respondents scoring one point higher on goal setting will have an average score 
of 0.233 points higher on the dependent variable- the likelihood of CBD use. Next, 
adding the β3 estimate value (.079) from the coefficients table then multiplying the 
participants’ actual Perception_Sum score in the model will determine the participants’ 
estimated likelihood of CBD use value. Assessing significance, goal setting (p = .000), 
which is less than the established significance level of 0.05, as well as the construct self-
efficacy (p = .001), and situational perception (p = .035). In conclusion, all independent 
variables in Model 3 show statistical significance in predicting the likelihood of using 
CBD for GAD. This section of analysis enabled me to gain a deeper understanding by 
analyzing the size of the relation and the direction of the association between the 




Research Question 2 
Research Question 2: To what extent are knowledge, outcome expectations and 
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the 
application of an effective treatment protocol associated with the likelihood of CBD 
usage in generalized anxiety disorder, while controlling for age, gender, level of 
education, and generalized anxiety disorder scores? 
H02: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are not associated with the likelihood of CBD usage in 
generalized anxiety disorder while controlling for age, gender, level of education, 
and generalized anxiety disorder scores.   
Ha2: Knowledge, outcome expectations and expectancies, situational perceptions, 
self-efficacy in using CBD, and goal setting for the application of an effective 
treatment protocol are associated with the likelihood of CBD usage in generalized 
anxiety disorder while controlling for age, gender, education level, and 
generalized anxiety disorder scores. 
The descriptive statistics output for RQ2 includes the continuous age, revealing 
this measurement of central tendency (M = 55.18). The choices for gender included 1 = 
female, 2 = male, 3 = LGBTQ, 4 = other, and 5 = prefer not to answer. Here, (M = 1.19), 
thus revealing that the sample was predominantly female. In assessing the mean for 
education level, with choices including 1 = less than high school, 2 = high school or 




6 = master’s degree, 7 = Ph.D. or other doctoral degree, and 8 = prefer not to answer, 
one can gather from assessing the descriptive statistics table that most of the sample holds 
a bachelor’s degree (M = 5.10).  
In an assessment of GAD scores, with a potential scoring range of 0-21 (M = 
6.65). The correlations output for RQ2 include the controlling variables- age, gender, 
level of education, and GAD-7 scores, showcased several of these inverse correlations, 
meaning that as there is an increase in the value of one of the variables, the value of the 
other variable decreases. See Table 7 below.  
Table 7  
Descriptive Statistics for the Study Variables for RQ2 
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The model summary table highlights the amount of variance that exists in three of 




displays the result of .663 adjusted R-square. This test enabled me to conclude that .633 
(or 63.3%) of likelihood CBD use results from three of the SCT constructs.  
In Model 3, there are three predictors, including goal setting, self-efficacy, and 
perception. The adjusted R-squared result of .633 reveals that the combination of these 
three predictor variables explains 63% of the variance in the dependent variable. While 
the adjusted R-squared creates an estimation of the population total that is under 
examination, the R-Square is a representation of the proportion of the variance in the 
dependent variable (Miles, 2014). This statistic enabled me to conclude that .633 of the 
variance  of the self-reported likelihood of using CBD for GAD was explained by three 
predictors, including goal setting, self-efficacy, and perception. The table displays 
information about the regression line and the ability of this statistical test to explain the 
total variation in the dependent variable- the likelihood of CBD use.  
In the final statistical test, the coefficients table provided multiple values that 
enabled me to analyze the regression. The output highlights the constructs that have 
contributed most significantly to the outcome variable, the likelihood of CBD use. As 
noted in the unstandardized coefficients, those study participants who scored one point 
higher on the SCT construct- goal setting, will score, on average, 0.233 points higher on 
the dependent variable- the likelihood of CBD use. Repeating this process, one notes 
significance in goal setting (p = .000), below the established significance level of 0.05. 
Self-efficacy (p = .001), and perception (p = .035) both proving to be statistically 
significant. In conclusion, all three of the IVs, including goal setting, self-efficacy, and 





likelihood of using CBD for GAD. In an assessment of the size of the relationship and the 
direction of association between the predictor and response variables in Model 3, the 
results are in Table 8 below.   
Table 8  
Regression Coefficients of SCT Constructs on Likelihood of CBD Usage   
 
Variable    B 95%CI      β   t p 
P       
(constant)  .256  -.548, 1.060   .632  .529  
Goal Setting  .233  .191, .276     .761  10.911  .000  
Self-Efficacy -.075  -.117, -.032    -.209   -3.464  .001  
Perception  .079  .006, .152     .144    2.133  .035  
      
𝑅2 = .643, Adjusted 𝑅2 = .633, 𝐹(3, 110) = 65.903,   𝑝 ≤ .0001 
Summary 
In this chapter, the items relevant to this study and incorporated into the analysis 
include descriptive statistics. For analyzing the extent to which each of the quantitatively 
measured variables exists in relationship to each other, there was an assessment of the 
correlations table for both research questions. To discover pertinent information 
regarding the regression line, the model summary provided the ability to glean a deeper 
understanding of the total variation of the dependent variable- the likelihood of CBD 
usage. The ANOVA summary was analyzed to determine if significant statistical 
differences exist between the means of three or more independent variables. The 




understanding of the relationship size and direction between predictor and response 
variables.  
To this end, a summarization of the findings follows: The optimal model remains 
the representation found in RQ1. From this dataset, one notes the strongest correlation 
between goal setting and the likelihood of CBD use (r = .768, p = 0.00). A high 
correlation also exists between perception and expectations (r = .594, p = .000). There 
was initially no notable correlation between x and y. However, after using the stepwise 
regression method in SPSS, goal setting was selected as a key variable in the model. 
Model 3 consisted of goal setting, self-efficacy, and situational perception, as the optimal 
model in predicting the self-reported likelihood of using CBD for GAD. These results 
enable determining if the gap that brought this study to fruition has been met. A further 
examination of the potential limitations of this study and an exploration of potential 




Chapter 5: Discussion, Conclusions, and Recommendations 
The intent of this cross-sectional study was to examine the ability of the five 
constructs of the SCT in predicting the self-reported likelihood of CBD usage for GAD. I 
also sought to determine if an association existed between the SCT constructs and the 
possibility of CBD use while examining if influence resulted from the mediating effects 
of age, gender, level of education, and GAD scores. The over-arching goal of this inquiry 
was to discover the associations between the SCT constructs and CBD usage and if the 
moderating variables impacted the relationship between the constructs and the likelihood 
of CBD usage.  
In this study, the theoretical framework of SCT aided in discovering if there was 
reciprocity between the participant’s environment and certain behavioral factors. The 
primary tenet of the SCT is that the subscriber embraces an agentic vantage point to the 
behavioral characteristics of self-reflection, proactivity, self-organization, and self-
regulation (Bandura, 2005). This study illuminated three SCT constructs, namely goal 
setting, self-efficacy, and situational perception, that were significantly associated with 
the dependent variable: the likelihood of CBD usage.  
Interpretation of the Findings 
To my knowledge, there has been no study that has investigated the likelihood of 
using CBD for GAD while applying the SCT constructs as a mechanism to predict the 
likelihood of usage. However, comprehensive studies have been conducted that applied 
SCT to assessing and addressing those social-behavioral perceptions that aid in 




setting has also been influential and abundant in other medication protocol-compliance 
training (Miller & Bauman, 2014). In this study, goal setting was the construct that 
ranked the highest significance in influencing the mechanisms that underlie self-reported 
behavioral modulation, thus exhibiting significance in increasing the likelihood of using 
CBD for GAD.  
The findings in this study showed self-efficacy also contributed to increasing the 
likelihood of CBD use for GAD. With a focus on self-efficacy, it is notable that this SCT 
construct commonly ranks most substantially in influencing behavioral change 
implementation (Bennett et al., 2018). With the recognition that adherence to a 
medication protocol remains one of the biggest challenges for healthcare workers and 
clinicians, academic studies have provided an understanding that there are three distinct 
and quantified stages, including the initiation phase, the act of implementation, and 
discontinuation of the protocol (Okuboyejo et al., 2018). Self-efficacy has been strongly 
correlated with the adherence to medication regimens in treating HIV and other complex 
treatment protocols (Johnson et al., 2007). Okuboyejo et al. (2018) asserted that through 
probing into a plethora of instructional innovations that have incorporated self-efficacy, it 
is notable that there is a greater likelihood to engage in compliance-building behaviors 
when the patient gains the ability to maintain the necessary self-confidence to do so.   
Situation perception, an SCT construct that also proved to be significant in this 
study, has also been correlated with successful adherence to treatment protocols in 
various academic research. One study examined the study participant’s illness perception 




utilizing a questionnaire that probed the patient’s perception of the malady of which the 
individual has been plagued (Alluhayyan et al., 2020). Dehdari & Dehdari (2019) 
conducted a similar study with patients diagnosed with Type 2 diabetes. Their conclusion 
was with the recognition that gaining insight into one’s perception of the unique internal 
and external situational positions needs consideration when seeking to increase 
medication adherence and wellness-supportive therapies (Dehdari & Dehdari, 2019). 
Specifically, these researchers pointed to three-pronged situational subthemes: 
• Patient’s comfort level with medication style including consideration of one’s 
belief in complementary and alternative medicine versus the allopathic healthcare 
model. 
• An examination of one’s confidence in potential treatment effectiveness. 
• Examining the patient on these core issues regarding disease perception aided in 
increasing health-supportive behaviors.     
Although anyone 18 years of age or older struggling with generalized anxiety was 
invited to participate in this study, most respondents were females with a mean age of 55 
years. Some research intimates that females are more likely than males to become aware 
of their uncontrollable and chronic level of worry (Hantsoo & Epperson 2017). This fact 
might aid in understanding why more middle-aged women were quicker to agree to 
assess the role that anxiety plays while exercising consideration to explore the likelihood 
of taking CBD for potentially diminishing the uncontrollable anxiety levels.  
Some of the data collected from the survey questionnaire for the construct 




2018 determined that CBD was to be extracted from industrial hemp rather than the 
marijuana plant.” Eighty respondents (70%) answered: “don’t know.” Eighty-eight of the 
respondents (77%) answered false to Question 2: “CBD is not available in a variety of 
potencies.” Question 3 explored if “CBD is commonly used to treat generalized anxiety 
disorder,” with 90 respondents (78%) answering true.  
Question 4 explored if those surveyed believed that “CBD cannot resolve the root 
cause of generalized anxiety disorder,” and sixty-nine participants (60%) answered true. 
Question 5 examined the sample knowledge of whether “In the United States, more than 
40 million adults suffer from a generalized anxiety disorder,” with eighty-seven 
respondents (76%) answering true. It is noteworthy that only one respondent (0.008%) 
answered false to Question 5. 
Ninety-six respondents (84%) recognized that “generalized anxiety is a public 
health problem,” as probed in Question 6. Question 7 examined if the “occasional anxiety 
is considered normal, while chronic stress is not.” Here, ninety individuals answered true 
(78%). Ninety-seven respondents (85%) answered false to Question 8, which examined 
the sample’s understanding of the effect of CBD while equating it to that of marijuana- 
“Taking CBD has the same effect as smoking marijuana.” Here, only two respondents 
(0.01%) answered true to Question 8. Question 9 probed if “all CBD is sourced from the 
same high-quality raw material,” and eighty-eight (77%) answered false. Question 10 
was a query into if “CBD can be administered to children,” and 49 respondents (42%) 




After handing in the completed questionnaire, some participants quickly explored 
the feasibility of taking CBD for generalized anxiety with staff members. It illuminated 
that having been enlightened regarding the efficacy of CBD for generalized anxiety, it 
was notable that some participants were spurred into action to try CBD even though 
many did not initially have prior knowledge of the substance. Some individuals raised the 
point of taking CBD while simultaneously applying the SCT behavioral constructs to 
increase compliance. This level of interest in CBD and SCT unquestionably resonated 
immediately after filling out the survey questionnaire with at least ten respondents, 
primarily female. It was particularly noteworthy that one of the respondents reported 
back approximately a month after starting a CBD regimen. This individual revealed 
having had lifelong struggles with anxiety. Tearfully, this participant thanked us for the 
study, admitting that this opportunity had made a life-changing impact. Although 
potentially anecdotal, there were several other compelling interactions with participants 
who felt the need to convey appreciation for their enlightenment that resulted from the 
participation in this study.  
Assessing precisely how the findings of this study related to the study problem 
and research questions which drove this study, a recapitulation of the research questions, 
follows. RQ1 probed: To what extent are knowledge, outcome expectations and 
expectancies, situational perceptions, self-efficacy, and goal setting for the application of 
an effective treatment protocol associated with the likelihood of CBD usage in 
generalized anxiety disorder? RQ2 probed: To what extent are knowledge, outcome 




the application of an effective treatment protocol associated with the likelihood of CBD 
usage in generalized anxiety disorder while controlling for age, gender, level of 
education, and GAD-7 scores?  
A noted gap in the academic literature upon which this study was built addressed 
a lack of operational strategies enabling individuals to utilize CBD effectively. Moreover, 
another gap existed in the operational design of taking CBD- related explicitly to 
discovering solutions through which individuals could determine their effective dosage of 
CBD for GAD. I determined that knowledge and outcome expectations and expectancies 
were not significant predictors in increasing the likelihood of taking CBD effectively for 
GAD. However, in order of significance, goal setting, self-efficacy, and situational 
perception proved to be significant predictors of SCT when operationalized to potentially 
increase the likelihood of CBD usage. 
I determined through this study that the influence of these three constructs- goal 
setting, self-efficacy, and situational perception increased an individual’s likelihood of 
taking CBD effectively for GAD. Thus, the findings in this study have bridged a 
noticeable gap and notable lack in the academic research, which pointed to an absence of 
operational strategies in the scientific literature for the likelihood of taking CBD 
effectively for GAD. My findings supported that the SCT- the theoretical framework 
underlying this study, was instrumental in serving as a functional and effectual 
operational tool for this study. These findings can prompt positive social change on the 
individual level and the familial and community echelons. As noted in the implications 




community public health. Specifically, positive social change is primed through the 
dovetailing of the social cognitive theoretical framework with CBD use for GAD.  
Limitations of the Study 
Self-reporting questionnaires that probe participant’s subjective experience are 
not considered the gold standard and are often met with skepticism when compared to, 
for example, a face-to-face interview or a videoed interview (Erba et al., 2017). As this 
study sought to describe the sample within a population regarding an outcome- the 
likelihood of CBD use, a cross-sectional study design was suitable. This design is known 
to be beneficial at indicating associations (Levin, 2006). However, the same source points 
the potential limitation that stems from the fact that this type of probe occurs at only one 
point in time. Also, to minimize time and cost, this study utilized convenience sampling, 
which drew volunteers near the research’s place of business. Convenience sampling was 
likely the cause that the sample was relatively homogeneous and is a potential limitation 
of this study. 
Further assessment of potential limitations in this study, it is essential to consider 
the study location. This study was conducted in Fairfield County, Connecticut- an 
exceptionally high socioeconomic status community. Most of the individuals who 
responded to this study have the out-of-pocket expendable income to afford CBD, as it is 
a nutraceutical that is not covered by insurance. Therefore, through a lens of social 
stratification, if this study were conducted in low socioeconomic status locations 
throughout the United States, there would likely be a different outcome in the self-




more likely to gain awareness (Dickinson & Adelson, 2014) that anxiety has escalated to 
a level that needs treatment and can perhaps begin to manage the disorder before the need 
for medical intervention.  
Another consideration regarding potential limitations in this study is how 
representative the sample is regarding the population of interest and its proportional 
representation to the larger population. Although there is a diverse population that shops 
and consults at the holistic health center from where the questionnaire was made 
available, this study sample was not representative of this fact. Because of the 
overrepresentation of White females and those holding at least a bachelor’s degree, this 
narrow group creates the potential for issues of a lack of generalizability and external 
validity. Also, because shoppers in this SES sector are more likely to be agreeable with 
the cost of a high-level quality product, individuals can access quality-controlled CBD 
products. Other lower price point CBD formulations often do not yield the same potency 
of the active ingredient.  
This community is also unique in that individuals have awareness and knowledge 
of various brands of CBD made from high-quality raw materials and can quickly and 
consistently access those high-quality CBD products. Being located even in nearby 
neighborhoods throughout the relatively small state of Connecticut can minimize 
accessing high-quality CBD products. These facts could potentially play a role in 
diminishing the likelihood of taking CBD for GAD if the participants are not residing in 
or around Fairfield County, CT, or another high socioeconomic locale. The data analysis 




the sample holds a bachelor’s degree (M = 5.10). This apparent lack of diversity in the 
sample introduced a potential threat to external validity.   
This study investigated the self-reported likelihood of taking CBD for GAD. 
There were five predictor variables: knowledge, outcome expectations and expectancies, 
situational perception, self-efficacy in using CBD, and goal setting. The effect size = 0.15 
(medium), the alpha level = 0.05, the power = 0.80, and number of predictors 9 (five 
constructs of SCT and 4 covariates). Using these indices in G*Power, I determined that a 
sample size of 114 participants would confer a medium effect size. However, because 
there was a relatively low number of respondents (114), an analysis of subgrouping will 
likely not have the power to apply to a broader demographic. This relatively low sample 
size could play a role in diminishing the application to a larger population- decreasing 
generalizability.   
The overrepresentation of female participants increased the potential of 
introducing response bias. Assessing another form of response bias, social-desirability 
bias, can occur when respondents provide answers to survey questions that they feel 
would be favorably viewed by associates and friends (Krumpal, 2013). Although I 
conveyed to each participant before filling out the survey that it was of utmost 
importance to be blatantly honest with their answers, some might have felt that it was in 
their interest to frame CBD positively. Because some of the individuals who filled out the 
survey questionnaire are acquainted with me, social-desirability bias could have played a 
role in influencing the participants to answer in a manner that would have been deemed 




Recommendations for Further Studies 
Undoubtedly, GAD continues to be a growing public health concern, particularly 
through the COVID-19 pandemic (Bauerle et al., 2020) that unleashed serendipitously 
through the year-long time frame that this dissertation was written. The pandemic has 
brought cause for rapid adaptations as conventional medicine has experienced a sharp 
increase in prescriptions for benzodiazepines such as Xanax and Klonopin- while 
emerging evidence suggests that this class of medication is contraindicated for high-risk 
patients with respiratory issues (Ostuzzi et al., 2020). Learning further applications of 
CBD for sleep disorders, inflammatory conditions, and seizures disorders through the 
lens of SCT could aid this substance to be used safely and ultimately effectively while 
perhaps minimizing the common practice of recommending such highly addictive 
medications.   
Several studies have showcased strong associations between all the SCT 
constructs, including knowledge, outcome expectations/expectancies, situational 
perception, self-efficacy, and goal setting. However, this study found the three constructs 
specifically- goal setting, self-efficacy, and situational perception to be strong predictors 
of the dependent variable- the self-reported likelihood of using CBD for GAD. Moreover, 
while the sample size was purposefully and precisely calculated for this study, it would 
require further academic research to determine if a larger participant pool would prompt a 
different outcome. Another consideration is the length of time of the data collection 




quickly in this study, spreading the collection period over an extended time frame and to 
multiple diversified communities appears worthy of another probe. 
Implications for Practice 
Through the lens of public health, a problem exists in the United States, where 40 
million adults are diagnosed with GAD. Still, many individuals are unwilling to take a 
prescription medication to treat the condition, and the GAD will go untreated. Some are 
hesitant to try CBD even though much research is emerging about its potential benefits 
for GAD. This section looks at practical methods to aid practitioners and health educators 
in devising effective teaching methods about CBD usage. A review of these findings can 
serve to draw implications from the results of this study. The over-arching goal was to 
utilize what has been implicated in prompting further inquisitions. The following 
information will further operationalize the results obtained in this study, aiding experts in 
the field to apply a SCT-based teaching strategy to assist patients in increasing the 
likelihood of using CBD for GAD. 
Goal Setting in Advising Individuals to Take CBD for GAD 
As a potential strategy when taking a medication to aid in minimizing GAD, the 
act of goal setting can fortify one’s ability to increase adherence to a CBD protocol. This 
study showed that there is a benefit in taking steps that can improve compliance. 
Behaviors such a clarifying the intention of taking CBD to decrease GAD and then 
committing to taking measures such as daily journaling about the protocol have shown 
the promise of significantly increased the likelihood of taking CBD for GAD. For 




dosage. This effective dose depends upon the degree of imbalance of the newly 
discovered endocannabinoid system (Pertwee, 2006). Raising the patient’s awareness of 
goal setting steps such as envisioning what life would be like when no longer paralyzed 
with anxiety showed significance in increasing the likelihood of taking CBD for GAD. 
Encouraging individuals to create a reward system is beneficial in the goal setting process 
when considering implications for practice (Sharma, 2017).            
Self-efficacy in Advising Individuals to Take CBD for GAD 
Self-efficacy also proved to be a consequential construct of the SCT. Raising 
awareness of the importance of increasing one’s confidence in changing the unhealthy 
behavior increased the likelihood of taking CBD for GAD. Learning from an expert about 
ways to diffuse potential challenges can be liberating- thus minimizing the possible fear 
of failure and increasing self-assuredness of complying with a CBD protocol. Aligning 
with others in the spirit of a team-building peer support approach has also proven to be 
confidence bolstering when creating a new health-building behavior (Bussell, 2017). The 
same source asserts that behavioral confidence can be strengthened when hearing from an 
important role model such as an expert in the field or even a well-known celebrity touting 
a positive experience using CBD for GAD. 
Situational Perception in Advising Individuals to Take CBD for GAD 
Situational perception is one of the SCT constructs that serves to create a realistic 
sense of the circumstances the individual faces when embarking on a behavior. Some 
patients struggle and attempt to cope with highly destructive and uncontrollable anxiety 




convey how life experiences can be when not paralyzed with anxiety can be sobering and 
perspective-changing. Exploring one’s awareness, perception, and interpretation can be 
the start point to instituting practical steps to increase life skills, coping mechanisms, and 
diminishing out-of-control anxiety levels. For example, learning about the abundant 
research that has been done on CBD can be fortifying and reassuring. To aid in 
relinquishing dosing hesitancy, there is a benefit in guiding the patient to understand that 
CBD is a non-mind-altering substance. Modulating an individual’s situational perception 
also increased the likelihood of using CBD for generalized anxiety in this study.   
Implications for Social Change 
This study showcased that disease burden and comorbidities associated with a 
GAD could be positively influenced as individuals learn to take CBD more effectively 
through the behavioral restructuring brought about by the application of goal setting, self-
efficacy, and situational perception- three relevant constructs of SCT. This study 
highlighted that the SCT constructs could explain the likelihood of CBD usage for GAD. 
One of the values in determining these findings is that these outcomes can be harnessed 
to develop a training program that can facilitate taking CBD more effectively for GAD.  
Through the lens of public health, this study focused on those who have been 
diagnosed with GAD. With further consideration of the numbers of those individuals who 
remain undiagnosed with GAD, this study has indicated that there is prudence in creating 
tools that enable health educators to teach individuals those metered steps that may 
increase the likelihood of taking CBD for GAD. Applying behavioral change techniques 




results. Increasing the likelihood of CBD usage can induce positive social change on the 
individual level and potentially generate productive revisions in the family structure, the 
workplace, and eventually impacting societal transformations.  
Conclusions 
Generalized anxiety continues to be a public health threat as the number of 
individuals diagnosed and undiagnosed with generalized anxiety continues to spike 
upward. As a potential solution to this dilemma, this study sought to examine the SCT’s 
ability to predict the likelihood of using CBD for GAD. This study highlights the 
additional challenges of taking CBD for GAD and the extra responsibility required by 
health practitioners to ease individuals into taking CBD for conditions of anxiousness. 
While some medical practitioners treating patients with GAD are taking the time to teach 
patients about CBD usage, most are not- as this process calls upon a new skill set and 
requires more time than is typically allotted. This study determined that three SCT 
constructs increased the likelihood of taking CBD for generalized anxiety, including goal 
setting, self-efficacy, and situational perception. Hence, the application of the SCT 
increased the likelihood of individuals taking CBD- a protocol that is with the possibility 
of becoming a viable solution for the treatment of GAD.  
We are at a point in history where we are perpetually probing deeper into the 
scientific literature and discovering how to create more preventative, safer, efficacious, 
and cost-effective treatment protocols. The criterion for this progress was to find 
solutions with the most negligible adverse impacts on the human body while increasing 




learning to prevent the furthering of disease progression, reduce suffering- with an end 
goal of teaching patients to become a master of one’s health status. Doing so increases 
the individual’s ability to move toward the highest state of optimal health while 
minimizing risk and decreasing the level of need for sick-care treatments.  
Dovetailing complementary and alternative health treatments within the medical 
model is occurring more frequently. As this study considered the increased 
implementation of CBD for GAD, there was a discovery that has the potential of 
contributing value to the preventative healthcare model. Standardizing these findings into 
a SCT-based teaching protocol can create interest for service providers of a practical 
implementation that has shown to increase the ease of taking CBD for GAD. On a 
grander scale, making inroads that can expose’ the increased likelihood of using CBD for 
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Appendix A: Instrument 
Section 1: Knowledge of Cannabidiol (CBD) and Generalized Anxiety Disorder 
PLEASE CIRCLE THE ONE ANSWER THAT YOU MOST AGREE WITH 
___________________________________________True     False    Don’t Know    
1. The Farm Bill of 2018 determined that CBD             
is to be extracted from industrial hemp 
rather than the marijuana plant.                                  T             F                ? 
                                 
2. CBD is not available in a variety of potencies.          T              F               ?  
                                                                     
3. CBD is commonly used to treat                                                                                
generalized anxiety disorder.                                      T              F               ? 
      
4. CBD cannot resolve the root cause of                                                                    
generalized anxiety disorder.                                      T              F               ? 
 
5. In the United States, more than 40                                                                   
million adults suffer from a                                                                     
generalized anxiety disorder.                                      T              F                ? 
 
6. Generalized anxiety disorder is a public                                                               
health problem.                                                           T              F                ? 
 
7. While occasional anxiety is considered                                                                     
normal, chronic stress is not.                                      T              F                ?   
                           
8. Taking CBD has the same effect as                                                                           
smoking marijuana.                                                     T             F                ? 
 
9. All CBD is sourced from high-quality material.         T             F                ? 
 










Section 2a: Outcome Expectations 
 
PLEASE CIRCLE THE ONE ANSWER WITH WHICH YOU MOST AGREE 
                                                    No   Probably Not   Maybe   Probably   Highly Likely 
11. Taking CBD can 
 eliminate mild                                                           
  to severe levels 
  of anxiety.                       0               1                 2                3                  4                  
12.  A benefit of  
 regular CBD use 
 is the relief of 
 inflammation.                 0               1                 2                3                  4  
13.  Many CBD users 
 experience higher  
   levels of focus 
   and concentration 
   as their anxiety 
   subsides.                         0               1                2                3                  4            
14.  Some people no 
 longer need  
 anxiety 
 medication,  
 because of  
 taking CBD.                     0               1               2                3                  4  
15.  Some CBD users 
 report that close  
 relations have 
 noticed they seem 
 less anxious.                     0               1                2                3                 4  
 
**************************************************************** 











Section 2b: Outcome Expectancies 
  PLEASE  CIRCLE THE  ONE ANSWER WITH  WHICH  YOU MOST  AGREE      
                                              Not at all     Not Very   Somewhat                           Very 
                                             Important   Important  Important  Important   Important 
 
16.  It is important  
 to you that you  
 eliminate mild  
 to severe levels  
 of anxiety.                        0                 1                   2                  3                4      
17.  It is important to 
 you that there 
 are added benefits 
 from taking CBD- 
 such as relief of 
 inflammation.                   0                 1                   2                  3                4        
18.  It is important to 
 you that, as your 
 anxiety lessens,  
 you will have 
 better focus 
 and concentration.            0                 1                   2                 3                 4          
19.  It is important to 
 you to stop taking 
 prescription  
 medication as 
 a result of  
 taking CBD.                      0                 1                   2                 3                 4             
20.  It is important to 
 you that close  
 relations will 
 witness you being 
 less anxious.                      0                 1                    2                 3                4           











Section 3: Situational Perceptions  
 
PLEASE CIRCLE THE ONE ANSWER  WITH  WHICH YOU  MOST AGREE 
                                                  No       Probably    Maybe     Probably       Highly   
                                                                        Not                                                 Likely     
21.  Abundant research 
 supports that CBD 
 is effective for 
  generalized anxiety 
  disorder (GAD).                 0               1                 2                3                 4            
22. There is adequate  
 time in my daily  
 schedule to maintain 
 a CBD regimen.                 0               1                2                3                  4          
23.  Medical doctors 
 recommend the use  
 of CBD for GAD.              0               1                2                3                  4             
24.   CBD is a “non-  
  mind-altering” 
  extract derived from  
  industrial hemp.                0               1                2                3                  4   
***************************************************************         
Section 4: Self-efficacy in Using CBD 
  ______________________________________________________________________ 
                                                        No        Probably      Maybe     Probably      Highly  
                                                                         Not                                                    Likely    
25.  I would be more 
 compliant with a CBD 
 dosing schedule if I 
 journaled each dose.            0              1                  2                 3                  4      
26.  Consulting with an  
 expert on how 
 to take CBD would  
 aid in staying steady                                                                                                       
 with the dosing.                   0              1                  2                 3                  4            
27.  Creating a support  
 system would help  
 me to stay motivated  
 with dosing CBD.                0             1                  2                  3                  4 
28.  To create a steady habit,  
 I would find it easier 





Section 5: Goal setting 
  
PLEASE  CIRCLE  ONE  ANSWER  WITH   WHICH  YOU  MOST   AGREE_  
                                                   No    Probably     Maybe     Probably     Highly     
                                                                      Not                                                 Likely_ 
29.  I intend to either begin 
 using or continue using 
  CBD for my anxiety.           0            1                2                 3                  4 
30.  I am willing to commit  
 to daily journaling so 
 that I can notate 
  how I feel as I adjust  
  the dosage of CBD.             0            1                 2                 3                 4 
31.  It is my goal to make 
 my life more fulfilling 
 by taking steps to relieve  
 generalized anxiety 
 disorder.                              0            1                 2                 3                 4 
32.  I am imagining what 
 life will be like when 
 I no longer experience 
 GAD as a result  
  of taking CBD.                    0            1                 2                 3                4 
******************************************************************* 
________________________________________________________________________ 
                                                       Not      Probably     Maybe     Probably      Highly 
                                                     At All        Not_________      ___  ______     Likely___   
33. How likely are you 
to use CBD to help 
              decrease your 
generalized anxiety 


















34. What is your age? ______ 
 
o Prefer Not to Answer 
 
35. What is your race/ethnicity? 
 
o White 
o Black or African American 
o American Indian or Alaskan Native 
o Asian 
o Native Hawaiian or another Pacific Islander 
o From multiple races 
o Some other race (Please specify) _________________ 
o Prefer Not to Answer 
 





o Other (Please specify) ___________________ 
o Prefer Not to Answer 
 






o Never Married 











38. What is the highest level of education you have completed? 
 
o Less than high school 
o High school or equivalent (e.g., GED) 
o Some college, but no degree 
o Associate degree 
o Bachelor’s degree 
o Master’s degree 
o Ph.D. or other Doctoral degrees  
o Prefer Not to Answer 
 
39. How much total combined income did all members of your household earn 
in 2019? 
 
o $0 - $9,999 
o $10,000 - $49,999 
o $50,000 - $79,999 
o $80,000 - $99,999 
o $100,000 or more 


















Generalized Anxiety Disorder Assessment (GAD-7) 
Over the past two weeks, how often have you been bothered by the following: 
(A)  Feeling nervous, anxious, or on edge? 
o Not at all (0) 
o Several days (+1) 
o More than half the days (+2) 
o Nearly every day (+3) 
(B)  Not being able to stop or control worrying?  
o Not at all (0) 
o Several days (+1) 
o More than half the days (+2) 
o Nearly every day (+3) 
(C)  Worrying too much about different things? 
o Not at all (0) 
o Several days (+1) 
o More than half the days (+2) 
o Nearly every day (+3) 
(D)  Trouble relaxing?  
o Not at all (0) 
o Several days (+1) 
o More than half the days (+2) 




(E)  Being so restless that it is hard to sit still? 
o Not at all (0) 
o Several days (+1) 
o More than half the days (+2) 
o Nearly every day (+3) 
(F)  Becoming easily annoyed or irritable? 
o Not at all (0) 
o Several days (+1) 
o More than half the days (+2) 
o Nearly every day (+3) 
(G)  Feeling afraid as if something awful might happen? 
o Not at all (0) 
o Several days (+1) 
o More than half the days (+2) 










Appendix B: Panel of Experts for Assessment of the Instrument Reliability, Content and 
Face Validity 
Practitioners with Expertise in the Area of Mental Health 
Andrew Golden, MA. LPC. LADC, is a Psychotherapist in private practice specializing 
in Mood Disorders, Anxiety, and Addiction.    agolden97@earthlink.net 
Dr. Wendy Wolfson, a DO/Clinical Psychiatrist, specializes in mood and generalized 
anxiety disorders. Dr. Wolfson has breadth and depth of knowledge of pharmaceuticals 
and nutraceuticals in the field of mental health.    drwendy@drwendywolfson.com 
Practitioners with Expertise in the Area of Instrumentation 
Dr. Leslie Elliott was the original Second Committee Member for this dissertation while 
also a doctoral student mentor at Walden University.  leslie.elliott@mail.waldenu.edu 
 
Dr. Clarence Schumaker, Ph.D., is the Second Committee Member and Approved 
Member Methodologist for this dissertation and a doctoral student mentor at Walden 
University.  clarence.schumaker@mail.waldenu.edu 
 
Dr. Cheryl Greene has a Ph.D. in Rhetoric and Linguistics and has taught in the Program 
of Writing and Rhetoric at Stanford University, the University of California Santa Cruz, 
and Arizona State University.  cherbs.greene@gmail.com 
 
Practitioners with Expertise in the Area of Social Cognitive Theory 
Dr. Nina Bell, Ph.D., MPH, Faculty for College of Health, Human Services, and Science 
at Ashford University, and Dissertation Mentor at Walden University. 
nina.bell@mail.waldenu.edu 
Dr. David Duncan, Ph.D., Contributing Faculty Member, School of Health Sciences, 
Walden University.   david.duncan@mail.waldenu.edu 
